{
  "meta": {
    "id": "test123",
    "title": "Mid Day Module (Pathology-2) - 2024-12-02",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A patient is diagnosed with a malignancy that is associated with an overexpression of the c-Myc gene. Which of the following is the most likely mechanism of this overexpression?",
      "options": [
        {
          "label": "A",
          "text": "Gene amplification",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chromosomal translocation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Point mutation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gene deletion",
          "correct": false
        }
      ],
      "correct_answer": "A. Gene amplification",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Gene amplification</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Chromosomal translocation: While chromosomal translocations can result in c-Myc overexpression , such as the translocation seen in Burkitt lymphoma (t(8;14), it is less common than gene amplification for the overexpression of c-Myc in a broader range of malignancies.</li><li>\u2022 Option B. Chromosomal translocation:</li><li>\u2022 c-Myc overexpression</li><li>\u2022 translocation seen in Burkitt lymphoma (t(8;14),</li><li>\u2022 overexpression of c-Myc</li><li>\u2022 Option C. Point mutation: Point mutations can activate oncogenes or inactivate tumor suppressor genes, but they are not typically associated with the overexpression of c-Myc. Instead , they might alter the function of the resulting protein.</li><li>\u2022 Option C. Point mutation:</li><li>\u2022 activate oncogenes</li><li>\u2022 inactivate tumor suppressor genes,</li><li>\u2022 overexpression of c-Myc. Instead</li><li>\u2022 Option D. Gene deletion: Gene deletion generally leads to a loss of gene function and is more commonly associated with tumor suppressor genes rather than proto-oncogenes like c-Myc. Deletion would not result in overexpression but rather in reduced expression or loss of function.</li><li>\u2022 Option D. Gene deletion:</li><li>\u2022 loss of gene function</li><li>\u2022 tumor suppressor genes</li><li>\u2022 proto-oncogenes like c-Myc. Deletion would not</li><li>\u2022 overexpression</li><li>\u2022 loss of function.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gene amplification is a common mechanism for overexpression of the c-Myc gene in various malignancies, leading to increased cell growth and proliferation due to the extra copies of the gene being transcribed.</li><li>\u27a4 Gene amplification</li><li>\u27a4 overexpression of the c-Myc gene</li><li>\u27a4 increased cell</li><li>\u27a4 growth and proliferation</li><li>\u27a4 extra copies of the gene</li><li>\u27a4 transcribed.</li><li>\u27a4 The C-myc gene is a proto-oncogene that codes for a transcription factor involved in cell proliferation and differentiation . Overexpression of c-Myc is seen in many malignancies, and it is often due to gene amplification, which results in an increased number of copies of the gene . Chromosomal translocations can also lead to c-Myc overexpression, but they are less common.</li><li>\u27a4 The C-myc gene is a proto-oncogene that codes for a transcription factor involved in cell proliferation and differentiation . Overexpression of c-Myc is seen in many malignancies, and it is often due to gene amplification, which results in an increased number of copies of the gene .</li><li>\u27a4 C-myc gene is a proto-oncogene</li><li>\u27a4 transcription factor</li><li>\u27a4 cell proliferation and differentiation</li><li>\u27a4 Overexpression of c-Myc</li><li>\u27a4 gene amplification,</li><li>\u27a4 increased number of copies of the gene</li><li>\u27a4 Chromosomal translocations can also lead to c-Myc overexpression, but they are less common.</li><li>\u27a4 Chromosomal translocations</li><li>\u27a4 lead to c-Myc overexpression,</li><li>\u27a4 less common.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7c260c1",
      "audio": ""
    },
    {
      "text": "Which of the following are oncofetal antigens? Alpha-fetoprotein Carcinoembryonic antigen Human chorionic gonadotropin Placental alkaline phosphatase Immunoglobulins",
      "options": [
        {
          "label": "A",
          "text": "1 and 3",
          "correct": false
        },
        {
          "label": "B",
          "text": "1, 3 and 4",
          "correct": false
        },
        {
          "label": "C",
          "text": "3, 4 and 5",
          "correct": false
        },
        {
          "label": "D",
          "text": "1 and 2",
          "correct": true
        }
      ],
      "correct_answer": "D. 1 and 2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 1 and 2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.</li><li>\u2022 Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.</li><li>\u2022 Alpha-fetoprotein is a valuable clinical aid in diagnosis, prognosis, and monitoring of the following tumors:</li><li>\u2022 Alpha-fetoprotein</li><li>\u2022 diagnosis, prognosis, and monitoring of the following tumors:</li><li>\u2022 Primary hepatocellular carcinoma Hepatoblastoma Non-seminomatous testicular germ cell tumors Embryonal carcinoma Teratomas Choriocarcinoma</li><li>\u2022 Primary hepatocellular carcinoma</li><li>\u2022 Hepatoblastoma</li><li>\u2022 Non-seminomatous testicular germ cell tumors</li><li>\u2022 Embryonal carcinoma</li><li>\u2022 Teratomas</li><li>\u2022 Choriocarcinoma</li><li>\u2022 Carcinoembryonic antigen is normally detected in the glycocalyx of fetal epithelial cells . It is useful in detection, assessing recurrence, and prognosis of the following tumors:</li><li>\u2022 Carcinoembryonic antigen</li><li>\u2022 glycocalyx of fetal epithelial cells</li><li>\u2022 detection, assessing recurrence, and prognosis</li><li>\u2022 Adenocarcinoma of lung Colorectal carcinoma</li><li>\u2022 Adenocarcinoma of lung</li><li>\u2022 Colorectal carcinoma</li><li>\u2022 CEA levels >5 g/dL are noted in ascitic fluid associated with malignancy.</li><li>\u2022 CEA levels >5 g/dL</li><li>\u2022 ascitic fluid</li><li>\u2022 malignancy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alpha-fetoprotein and carcinoembryonic antigen are oncofetal antigens , which are expressed during fetal development and re-expressed in certain malignancies, aiding in the diagnosis, prognosis, and monitoring of these cancers.</li><li>\u27a4 Alpha-fetoprotein and carcinoembryonic antigen</li><li>\u27a4 oncofetal antigens</li><li>\u27a4 fetal development and re-expressed</li><li>\u27a4 malignancies,</li><li>\u27a4 diagnosis, prognosis, and monitoring of these cancers.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f823be8",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient notices spontaneously appearing and disappearing painful, linearly arranged nodules in different parts of the body. Which of the following malignancies is not associated with this clinical presentation?",
      "options": [
        {
          "label": "A",
          "text": "Uterine carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pancreatic carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bronchogenic carcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bladder carcinoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Bladder carcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Bladder carcinoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Uterine carcinoma: Uterine carcinoma, particularly when adenocarcinoma , can be associated with Trousseau syndrome due to its propensity to induce a hypercoagulable state , leading to venous thromboembolism.</li><li>\u2022 Option A. Uterine carcinoma:</li><li>\u2022 adenocarcinoma</li><li>\u2022 Trousseau syndrome</li><li>\u2022 propensity to induce a hypercoagulable state</li><li>\u2022 venous thromboembolism.</li><li>\u2022 Option B. Pancreatic carcinoma: Pancreatic carcinoma is strongly associated with Trousseau syndrome . The tumor's release of mucins and procoagulant substances can trigger a hypercoagulable state .</li><li>\u2022 Option B. Pancreatic carcinoma:</li><li>\u2022 Pancreatic carcinoma</li><li>\u2022 Trousseau syndrome</li><li>\u2022 mucins and procoagulant substances</li><li>\u2022 hypercoagulable state</li><li>\u2022 Option C. Bronchogenic carcinoma: Bronchogenic carcinoma, especially adenocarcinoma subtype, is known to produce substances that activate the coagulation system, thus it can be associated with Trousseau syndrome.</li><li>\u2022 Option C. Bronchogenic carcinoma:</li><li>\u2022 adenocarcinoma subtype,</li><li>\u2022 activate the coagulation system,</li><li>\u2022 Trousseau syndrome.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Bladder carcinoma is not commonly associated with Trousseau syndrome , which is characterized by migratory thrombophlebitis and is often seen with deep-seated adenocarcinomas like those of the pancreas, lung, and other visceral organs.</li><li>\u27a4 Bladder carcinoma</li><li>\u27a4 not</li><li>\u27a4 Trousseau syndrome</li><li>\u27a4 migratory thrombophlebitis</li><li>\u27a4 deep-seated adenocarcinomas</li><li>\u27a4 pancreas, lung, and other visceral organs.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b28a414e",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient presents with loss of weight and appetite. On clinical examination, grade IV clubbing is evident. Imaging shows periosteal new bone formation and left knee joint effusion. Which of the following tumors is associated with this condition?",
      "options": [
        {
          "label": "A",
          "text": "Bronchogenic carcinoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Carcinoma of the pancreas",
          "correct": false
        },
        {
          "label": "C",
          "text": "Esophageal carcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute myeloid leukemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Bronchogenic carcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Bronchogenic carcinoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Carcinoma of the pancreas: While patients with pancreatic cancer may develop paraneoplastic syndromes, hypertrophic osteoarthropathy is not typically associated with this type of malignancy.</li><li>\u2022 Option B. Carcinoma of the pancreas:</li><li>\u2022 paraneoplastic syndromes, hypertrophic osteoarthropathy</li><li>\u2022 not</li><li>\u2022 type of malignancy.</li><li>\u2022 Option C. Esophageal carcinoma: Esophageal carcinoma can be associated with paraneoplastic phenomena including clubbing , but it is less commonly associated with hypertrophic osteoarthropathy compared to bronchogenic carcinoma.</li><li>\u2022 Option C. Esophageal carcinoma:</li><li>\u2022 Esophageal carcinoma</li><li>\u2022 paraneoplastic phenomena</li><li>\u2022 clubbing</li><li>\u2022 less</li><li>\u2022 hypertrophic osteoarthropathy</li><li>\u2022 Option D. Acute myeloid leukemia: Hematologic malignancies like AML are not commonly associated with hypertrophic osteoarthropathy . Paraneoplastic syndromes are more commonly associated with solid tumors.</li><li>\u2022 Option D. Acute myeloid leukemia:</li><li>\u2022 Hematologic</li><li>\u2022 AML</li><li>\u2022 not</li><li>\u2022 hypertrophic osteoarthropathy</li><li>\u2022 Paraneoplastic syndromes</li><li>\u2022 solid tumors.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypertrophic osteoarthropathy is characterized by the following:</li><li>\u27a4 Hypertrophic osteoarthropathy</li><li>\u27a4 Periosteal new bone formation , primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges Arthritis of the adjacent joints Clubbing of the digits</li><li>\u27a4 Periosteal new bone formation , primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</li><li>\u27a4 Periosteal new bone formation</li><li>\u27a4 distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</li><li>\u27a4 Arthritis of the adjacent joints</li><li>\u27a4 Arthritis of the adjacent joints</li><li>\u27a4 Clubbing of the digits</li><li>\u27a4 Clubbing of the digits</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93ffddf3",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents with fever, sore throat, and lymphadenopathy. Serological tests are positive for Epstein-Barr virus (EBV) infection. Which of the following statements about the pathophysiology of EBV is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "It uses the complement receptor CD21 to attach and infect B cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is implicated in B-cell lymphomas in immunosuppressed people",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is a potent inducer of B-cell growth and transformation",
          "correct": false
        },
        {
          "label": "D",
          "text": "EBV infection always results in Burkitt lymphoma",
          "correct": true
        }
      ],
      "correct_answer": "D. EBV infection always results in Burkitt lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) EBV infection always results in Burkitt lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It uses the complement receptor CD21 to attach and infect B cells. This is correct. EBV uses the CD21 receptor , which is the complement receptor on B cells, to infect them .</li><li>\u2022 Option A. It uses the complement receptor CD21 to attach and infect B cells.</li><li>\u2022 correct. EBV</li><li>\u2022 CD21 receptor</li><li>\u2022 complement receptor on B cells, to infect them</li><li>\u2022 Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression. True. EBV is associated with various B-cell lymphomas, especially in individuals who are immunosuppressed, such as those with HIV or post-transplant patients.</li><li>\u2022 Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression.</li><li>\u2022 True. EBV</li><li>\u2022 B-cell lymphomas,</li><li>\u2022 immunosuppressed,</li><li>\u2022 HIV or post-transplant patients.</li><li>\u2022 Option C. It is a potent inducer of B-cell growth and transformation. This is correct. EBV can drive B-cell growth and transformation , contributing to the development of diseases like infectious mononucleosis and , in some cases, B-cell lymphomas.</li><li>\u2022 Option C. It is a potent inducer of B-cell growth and transformation.</li><li>\u2022 correct. EBV</li><li>\u2022 B-cell growth and transformation</li><li>\u2022 infectious mononucleosis and</li><li>\u2022 B-cell lymphomas.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 EBV infection does not always lead to Burkitt lymphoma . While EBV can infect B cells and is associated with various lymphomas, the outcome of infection ranges from asymptomatic to infectious mononucleosis, with only a minority progressing to Burkitt lymphoma or other types of B-cell lymphoma.</li><li>\u27a4 EBV infection does not</li><li>\u27a4 Burkitt lymphoma</li><li>\u27a4 EBV</li><li>\u27a4 B cells</li><li>\u27a4 various lymphomas,</li><li>\u27a4 asymptomatic to infectious mononucleosis,</li><li>\u27a4 minority progressing to Burkitt lymphoma</li><li>\u27a4 B-cell lymphoma.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 326</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 326</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1abbd325",
      "audio": ""
    },
    {
      "text": "Which of the following mechanisms does not lead to immune evasion by the tumor cells?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of PD1 receptor on T-cells",
          "correct": true
        },
        {
          "label": "B",
          "text": "Upregulation of expression of PDL1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Induction of galectin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Induction of regulatory T-cells",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of PD1 receptor on T-cells",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Inhibition of PD1 receptor on T-cells</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Upregulation of expression of PDL1: Tumor cells often upregulate PD-L1, which binds to the PD1 receptor on T cells, leading to the inhibition of the immune response against the tumor, effectively allowing the tumor to evade the immune system.</li><li>\u2022 Option B. Upregulation of expression of PDL1:</li><li>\u2022 Tumor cells often upregulate PD-L1,</li><li>\u2022 PD1 receptor on T cells,</li><li>\u2022 inhibition of the immune response</li><li>\u2022 tumor,</li><li>\u2022 tumor to evade the immune system.</li><li>\u2022 Option C. Induction of galectin Tumor cells can induce galectins, which are beta-galactoside-binding proteins that can negatively regulate T-cell apoptosis , affect T-cell receptor signaling, or contribute to the creation of an immunosuppressive tumor microenvironment, facilitating immune evasion .</li><li>\u2022 Option C. Induction of galectin</li><li>\u2022 galectins,</li><li>\u2022 beta-galactoside-binding proteins</li><li>\u2022 negatively regulate T-cell apoptosis</li><li>\u2022 T-cell receptor signaling,</li><li>\u2022 immunosuppressive tumor microenvironment, facilitating immune evasion</li><li>\u2022 ; Option D. Induction of regulatory T-cells: Tumors may induce regulatory T cells (Tregs), which suppress the activation of the immune system and maintain tolerance to self-antigens, thus aiding in tumor immune evasion.</li><li>\u2022 Option D. Induction of regulatory T-cells:</li><li>\u2022 Tumors</li><li>\u2022 regulatory T cells (Tregs),</li><li>\u2022 tolerance to self-antigens,</li><li>\u2022 tumor immune evasion.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Inhibition of the PD1 receptor on T cells does not lead to immune evasion by tumor cells; rather, it activates the immune response against the tumor. PD1 receptor inhibition is a strategy used in cancer immunotherapy to overcome tumor-induced immune suppression.</li><li>\u27a4 Inhibition of the PD1 receptor on T cells does not</li><li>\u27a4 immune evasion</li><li>\u27a4 activates the immune response</li><li>\u27a4 tumor. PD1 receptor</li><li>\u27a4 cancer immunotherapy</li><li>\u27a4 tumor-induced immune</li><li>\u27a4 suppression.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 312</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 312</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fac0a49a",
      "audio": ""
    },
    {
      "text": "A 25-year-old man presents with anemia and abdominal pain. On examination, he has pigmented macules over the palms, soles, and oral mucosa. Further investigations reveal loss-of-function mutations of the STK11 gene. What is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "HNPCC",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gorlin syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Von Hipplel - Lindau syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Peutz Jeghers syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Peutz Jeghers syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Peutz Jeghers syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. HNPCC: HNPCC, also known as Lynch syndrome , is an autosomal dominant condition predisposing individuals to early-onset colorectal cancer and other malignancies . It is associated with mutations in mismatch repair genes, not STK11.</li><li>\u2022 Option A. HNPCC:</li><li>\u2022 Lynch syndrome</li><li>\u2022 autosomal dominant condition</li><li>\u2022 early-onset colorectal cancer and other malignancies</li><li>\u2022 mutations in mismatch repair genes,</li><li>\u2022 Option B. Gorlin syndrome: Gorlin syndrome, or nevoid basal cell carcinoma syndrome , is characterized by multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies . It is associated with mutations in the PTCH1 gene , not STK11.</li><li>\u2022 Option B. Gorlin syndrome:</li><li>\u2022 nevoid basal cell carcinoma syndrome</li><li>\u2022 multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies</li><li>\u2022 mutations in the PTCH1 gene</li><li>\u2022 Option C. Von Hippel-Lindau syndrome: Von Hippel-Lindau syndrome is a hereditary cancer syndrome associated with a variety of tumors, including hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas. It is related to mutations in the VHL gene .</li><li>\u2022 Option C. Von Hippel-Lindau syndrome:</li><li>\u2022 Von Hippel-Lindau syndrome</li><li>\u2022 hereditary cancer</li><li>\u2022 hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas.</li><li>\u2022 VHL gene</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Peutz-Jeghers syndrome is an autosomal dominant disorder associated with gastrointestinal polyps and mucocutaneous pigmentation, due to mutations in the STK11 gene , and it elevates the risk of multiple cancers .</li><li>\u27a4 Peutz-Jeghers syndrome</li><li>\u27a4 autosomal dominant disorder</li><li>\u27a4 gastrointestinal polyps and mucocutaneous pigmentation,</li><li>\u27a4 STK11 gene</li><li>\u27a4 risk of multiple cancers</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbec7565",
      "audio": ""
    },
    {
      "text": "A physician is considering the differential diagnoses for a patient's elevated serum tumor marker levels. Carcinoembryonic antigen (CEA) is known to be elevated in various malignancies and benign conditions. Which of the following conditions is NOT typically associated with an elevated CEA level?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic cirrhosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carcinoma colon",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carcinoma prostate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Emphysema",
          "correct": false
        }
      ],
      "correct_answer": "C. Carcinoma prostate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154619.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Carcinoma prostate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alcoholic cirrhosis Alcoholic cirrhosis can lead to elevated CEA levels. CEA is not specific for malignancy and can be raised in a variety of benign liver conditions, including cirrhosis, especially when related to alcohol use .</li><li>\u2022 Option A. Alcoholic cirrhosis</li><li>\u2022 elevated CEA levels.</li><li>\u2022 not specific</li><li>\u2022 malignancy</li><li>\u2022 benign liver conditions, including cirrhosis,</li><li>\u2022 alcohol use</li><li>\u2022 Option B. Carcinoma of the colon CEA levels are frequently elevated in colorectal cancer and can be used as a marker for monitoring treatment response or disease recurrence after the removal of the primary tumor .</li><li>\u2022 Option B. Carcinoma of the colon</li><li>\u2022 CEA</li><li>\u2022 elevated</li><li>\u2022 colorectal cancer</li><li>\u2022 treatment response or disease</li><li>\u2022 primary tumor</li><li>\u2022 Option D. Emphysema Chronic lung conditions, including emphysema, can also result in elevated CEA levels , even though these are not malignant conditions. Smoking, which is a risk factor for emphysema , can itself cause elevated CEA levels.</li><li>\u2022 Option D. Emphysema</li><li>\u2022 elevated CEA levels</li><li>\u2022 not malignant conditions. Smoking,</li><li>\u2022 risk factor</li><li>\u2022 emphysema</li><li>\u2022 elevated CEA levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Carcinoma of the prostate , is not associated with elevated CEA levels . Instead, prostate-specific antigen (PSA) is the tumor marker commonly elevated in prostate cancer . CEA is used primarily for monitoring colorectal cancer and can be elevated in various benign conditions , including liver and lung diseases .</li><li>\u27a4 Carcinoma of the prostate</li><li>\u27a4 not</li><li>\u27a4 elevated CEA levels</li><li>\u27a4 prostate-specific antigen (PSA)</li><li>\u27a4 tumor marker</li><li>\u27a4 prostate cancer</li><li>\u27a4 CEA</li><li>\u27a4 monitoring colorectal cancer</li><li>\u27a4 elevated</li><li>\u27a4 benign conditions</li><li>\u27a4 liver and lung diseases</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "881a6758",
      "audio": ""
    },
    {
      "text": "An 8-year-old child is referred to a dermatologist for several \"suspicious\" pigmented lesions on his face and neck. Further history reveals the patient has had problems seeing out of his right eye; he is referred to an ophthalmologist, who diagnoses ocular melanoma. Based on the patient\u2019s symptoms, the diagnosis of xeroderma pigmentosum is considered. This condition results from?",
      "options": [
        {
          "label": "A",
          "text": "Aberrant expression of a receptor tyrosine kinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "An inborn defect in DNA repair",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chemical carcinogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "DNA viral infection",
          "correct": false
        }
      ],
      "correct_answer": "B. An inborn defect in DNA repair",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) An inborn defect in DNA repair</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Aberrant expression of the gene for a receptor tyrosine kinase , such as the Her-2/neu gene product , can cause breast cancer .</li><li>\u2022 Option A.</li><li>\u2022 Aberrant expression</li><li>\u2022 gene</li><li>\u2022 receptor tyrosine kinase</li><li>\u2022 Her-2/neu gene product</li><li>\u2022 breast cancer</li><li>\u2022 Option C. Chemical carcinogens have highly reactive electrophile groups that directly damage DNA , leading to mutations and eventually cancer .</li><li>\u2022 Option C.</li><li>\u2022 Chemical carcinogens</li><li>\u2022 highly reactive electrophile groups</li><li>\u2022 damage DNA</li><li>\u2022 mutations and eventually cancer</li><li>\u2022 Option D. A retrovirus is responsible for the development of T-cell leukemia/lymphoma .</li><li>\u2022 Option D.</li><li>\u2022 retrovirus</li><li>\u2022 development of T-cell leukemia/lymphoma</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Xeroderma pigmentosum is a condition resulting from a hereditary deficiency in the nucleotide excision repair pathway , leading to an inability to repair UV-induced thymine dimers , with resultant increased skin and ocular malignancies .</li><li>\u27a4 Xeroderma pigmentosum</li><li>\u27a4 hereditary deficiency</li><li>\u27a4 nucleotide excision repair pathway</li><li>\u27a4 inability to repair UV-induced thymine dimers</li><li>\u27a4 increased skin and ocular malignancies</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "04bb66d4",
      "audio": ""
    },
    {
      "text": "An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bronchogenic carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thymoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Non-Hodgkin lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Squamous cell carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Thymoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Thymoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bronchogenic carcinoma: Bronchogenic carcinoma refers to a type of lung cancer originating from the bronchi . Although it can present with a mediastinal mass , it is not typically associated with pure red cell aplasia , which is a reduction in the production of red blood cells .</li><li>\u2022 Option A. Bronchogenic carcinoma:</li><li>\u2022 type of lung cancer</li><li>\u2022 bronchi</li><li>\u2022 mediastinal mass</li><li>\u2022 not</li><li>\u2022 pure red cell aplasia</li><li>\u2022 reduction in the production of red blood cells</li><li>\u2022 Option C. Non-Hodgkin lymphoma: Non-Hodgkin lymphoma is a diverse group of blood malignancies that includes any kind of lymphoma except Hodgkin's lymphomas . Types of Non-Hodgkin lymphoma can involve the mediastinum but are not typically associated with pure red cell aplasia.</li><li>\u2022 Option C. Non-Hodgkin lymphoma:</li><li>\u2022 diverse group of blood malignancies</li><li>\u2022 lymphoma</li><li>\u2022 Hodgkin's lymphomas</li><li>\u2022 Types of Non-Hodgkin lymphoma</li><li>\u2022 mediastinum</li><li>\u2022 not typically</li><li>\u2022 pure red cell aplasia.</li><li>\u2022 Option D. Squamous cell carcinoma: Squamous cell carcinoma can arise in various organs, including the lungs, but is not commonly associated with pure red cell aplasia or mediastinal masses unless it is metastatic from another primary location .</li><li>\u2022 Option D. Squamous cell carcinoma:</li><li>\u2022 Squamous cell carcinoma</li><li>\u2022 organs,</li><li>\u2022 not</li><li>\u2022 pure red cell aplasia or mediastinal masses</li><li>\u2022 metastatic from</li><li>\u2022 primary location</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thymomas are mediastinal tumors that may be associated with paraneoplastic syndromes, including pure red cell aplasia, which is characterized by a selective decrease in red blood cell precursors.</li><li>\u27a4 Thymomas</li><li>\u27a4 mediastinal tumors</li><li>\u27a4 paraneoplastic syndromes,</li><li>\u27a4 pure red cell aplasia,</li><li>\u27a4 decrease</li><li>\u27a4 red blood cell precursors.</li><li>\u27a4 Ref : Robbins 10th/e p493</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10th/e p493</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bf00069",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents to her primary care physician for a routine health check-up. She has no complaints and her medical history is unremarkable. She undergoes a Pap smear as part of her cervical cancer screening. The cytology report describes disorganized growth of cells with hyperchromatic nuclei. Which of the following best characterizes the cellular changes seen in this patient's Pap smear?",
      "options": [
        {
          "label": "A",
          "text": "Hypertrophy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dysplasia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Metaplasia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hyperplasia",
          "correct": false
        }
      ],
      "correct_answer": "B. Dysplasia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Dysplasia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypertrophy: Hypertrophy refers to an increase in the size of cells , leading to an increase in the size of the organ . It is usually seen in response to increased demand or stimulation by hormones or growth factors . Unlike hyperplasia , hypertrophy does not involve an increase in the number of cells . An example would be the increase in muscle mass due to exercise.</li><li>\u2022 Option A. Hypertrophy:</li><li>\u2022 increase in the size of cells</li><li>\u2022 increase in the size of the organ</li><li>\u2022 increased demand or stimulation by hormones or growth factors</li><li>\u2022 Unlike hyperplasia</li><li>\u2022 does not involve</li><li>\u2022 increase in the number of cells</li><li>\u2022 increase in muscle mass due to exercise.</li><li>\u2022 Option C. Metaplasia: Metaplasia is the reversible change from one type of cell to another due to abnormal stimulus , which can potentially predispose to malignancy if the stimulus persists . A classic example is Barrett\u2019s esophagus , where the normal squamous epithelium of the esophagus changes to a columnar epithelium in response to chronic gastric acid exposure .</li><li>\u2022 Option C. Metaplasia:</li><li>\u2022 reversible change from one type of cell to another due to abnormal stimulus</li><li>\u2022 predispose to malignancy</li><li>\u2022 persists</li><li>\u2022 Barrett\u2019s esophagus</li><li>\u2022 normal squamous epithelium of the esophagus changes to a columnar epithelium</li><li>\u2022 chronic gastric acid exposure</li><li>\u2022 Option D. Hyperplasia: Hyperplasia is an increase in the number of cells in an organ or tissue, which may subsequently increase the size of the organ or tissue. It is a response to a stimulus and is usually a controlled process . Hyperplasia can be a physiological response , such as the proliferation of glandular epithelium of the female breast at puberty or pathologic as seen in endometrial hyperplasia.</li><li>\u2022 Option D. Hyperplasia:</li><li>\u2022 an increase in the number of cells in an organ or tissue,</li><li>\u2022 increase the size of the organ or tissue.</li><li>\u2022 stimulus</li><li>\u2022 controlled process</li><li>\u2022 Hyperplasia</li><li>\u2022 physiological response</li><li>\u2022 proliferation of glandular epithelium</li><li>\u2022 female breast at puberty or pathologic</li><li>\u2022 endometrial hyperplasia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dysplasia, is a term used to describe disorganized growth of cells with varying size, shape, and orientation, often with hyperchromatic nuclei, suggestive of a precancerous state .</li><li>\u27a4 Dysplasia,</li><li>\u27a4 disorganized growth of cells with varying size, shape, and orientation,</li><li>\u27a4 hyperchromatic nuclei,</li><li>\u27a4 precancerous state</li><li>\u27a4 Ref : Robbins 10th/e p719-720</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10th/e p719-720</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "041743d6",
      "audio": ""
    },
    {
      "text": "A 32-year-old man presents to the emergency department with persistent abdominal pain and diarrhea. CT scan reveals the presence of a tumor in the pancreas. Biopsy confirms the diagnosis of pancreatic adenocarcinoma. Genetic testing reveals a mutation in the KRAS proto-oncogene. Which of the following best describes the role of KRAS in this case?",
      "options": [
        {
          "label": "A",
          "text": "Stimulation of apoptosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibition of angiogenesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Activation of cell cycle arrest",
          "correct": false
        },
        {
          "label": "D",
          "text": "Promotion of cell proliferation",
          "correct": true
        }
      ],
      "correct_answer": "D. Promotion of cell proliferation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Promotion of cell proliferation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 KRAS is a proto-oncogene that encodes for a protein involved in cell signaling pathways that regulate cell growth and division . Mutations in KRAS can lead to the activation of these pathways, promoting cell proliferation and survival . KRAS mutations are common in pancreatic adenocarcinoma and are associated with a poorer prognosis</li><li>\u2022 KRAS</li><li>\u2022 proto-oncogene</li><li>\u2022 cell signaling pathways</li><li>\u2022 cell growth and division</li><li>\u2022 Mutations in KRAS</li><li>\u2022 activation of these pathways, promoting cell proliferation and survival</li><li>\u2022 KRAS mutations</li><li>\u2022 pancreatic adenocarcinoma</li><li>\u2022 poorer prognosis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "709690c8",
      "audio": ""
    },
    {
      "text": "A 16-year-old male presents with jaundice and anemia. His blood smear shows spherical red blood cells, and laboratory tests reveal an increase in mean corpuscular hemoglobin concentration (MCHC). Which of the following is the most likely cause of his anemia?",
      "options": [
        {
          "label": "A",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Megaloblastic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anemia of chronic disease \u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hereditary spherocytosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Hereditary spherocytosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. \u00a0Hereditary spherocytosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Iron deficiency anemia: It is characterized by a decrease in the amount of hemoglobin in red blood cells, leading to a decreased MCHC .</li><li>\u2022 Option A. Iron deficiency anemia:</li><li>\u2022 decrease in the amount of hemoglobin</li><li>\u2022 decreased MCHC</li><li>\u2022 Option B. Megaloblastic anemia: It can be associated with vitamin B12 or folate deficiency and ha s macrocytosis . This condition is associated with a normal or decreased MCHC.</li><li>\u2022 Option B. Megaloblastic anemia:</li><li>\u2022 vitamin B12 or folate deficiency</li><li>\u2022 s macrocytosis</li><li>\u2022 normal or decreased MCHC.</li><li>\u2022 Option C. Anemia of chronic disease: The anomie is often normocytic and normochromic , with a normal MCH</li><li>\u2022 Option C. Anemia of chronic disease:</li><li>\u2022 normocytic and normochromic</li><li>\u2022 normal MCH</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hereditary spherocytosis often presents with an elevated MCHC due to the spherical shape of red blood cells , which concentrates the haemoglobin content</li><li>\u27a4 Hereditary spherocytosis</li><li>\u27a4 elevated MCHC</li><li>\u27a4 spherical shape of red blood cells</li><li>\u27a4 haemoglobin content</li><li>\u27a4 Ref : Robbins 10 th / 639</li><li>\u27a4 Ref : Robbins 10 th / 639</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5c7e20d",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman with a history of rheumatoid arthritis presents with fatigue and pallor. Her blood tests show mild anemia. Additional laboratory tests are ordered to determine the cause of her anemia. Which of the following laboratory findings is most consistent with a diagnosis of anemia of chronic disease?",
      "options": [
        {
          "label": "A",
          "text": "Serum ferritin is decreased",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reduced hepcidin levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transferrin saturation is decreased",
          "correct": true
        },
        {
          "label": "D",
          "text": "Total iron binding capacity is increased \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "C. Transferrin saturation is decreased",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Transferrin saturation is decreased</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  In iron deficiency anemia , serum ferritin, which reflects body iron stores, is decreased.</li><li>\u2022 Option A.  In iron deficiency anemia</li><li>\u2022 serum ferritin,</li><li>\u2022 iron stores, is decreased.</li><li>\u2022 Option B. Hepcidin levels are typically increased in anemia of chronic disease because it is an inflammatory marker that blocks the release of iron from body stores, contributing to the anemia.</li><li>\u2022 Option B. Hepcidin</li><li>\u2022 increased in anemia of chronic disease</li><li>\u2022 blocks the release of iron</li><li>\u2022 Option D. In anemia of chronic disease, TIBC is usually normal or decreased , not increased , because the body's iron is sequestered due to inflammation and is not readily available for erythropoiesis.</li><li>\u2022 Option D. In anemia</li><li>\u2022 TIBC</li><li>\u2022 normal or decreased</li><li>\u2022 not increased</li><li>\u2022 body's iron is sequestered</li><li>\u2022 inflammation</li><li>\u2022 not readily available for erythropoiesis.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In anemia of chronic disease , transferrin saturation is decreased due to limited iron utilization, despite adequate or increased iron stores reflected by normal or increased serum ferritin levels.</li><li>\u27a4 anemia of chronic disease</li><li>\u27a4 transferrin saturation</li><li>\u27a4 decreased due to limited iron utilization,</li><li>\u27a4 adequate or increased iron</li><li>\u27a4 stores</li><li>\u27a4 normal or increased serum ferritin levels.</li><li>\u27a4 Ref : Robbins 10th/e p658</li><li>\u27a4 Ref : Robbins 10th/e p658</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9a22a8e9",
      "audio": ""
    },
    {
      "text": "A 25-year-old female presented with fatiguability and dyspnea on exertion. She was found to be having a hemoglobin of 6 g/dL. What will be most likely finding in her peripheral blood smear?",
      "options": [
        {
          "label": "A",
          "text": "Macrocytic hypochromic red cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "Target cells",
          "correct": false
        },
        {
          "label": "C",
          "text": "Reduced poikilocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Microcytic and hypochromic red cell",
          "correct": true
        }
      ],
      "correct_answer": "D. Microcytic and hypochromic red cell",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Microcytic and hypochromic red cells</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Macrocytosis (larger than normal red cells) typically indicates a deficiency in vitamin B12 or folate , not iron. While hypochromia refers to red cells with reduced hemoglobin content, it is not typically associated with macrocytosis.</li><li>\u2022 Option A. Macrocytosis</li><li>\u2022 (larger than normal red cells)</li><li>\u2022 vitamin B12 or folate</li><li>\u2022 Option B. Target cells can be seen in various hemoglobinopathies, liver disease, and post-splenectomy, but they are not characteristic of iron deficiency anemia.</li><li>\u2022 Option B. Target cells</li><li>\u2022 hemoglobinopathies, liver disease, and post-splenectomy,</li><li>\u2022 Option C. Poikilocytosis refers to abnormally shaped red blood cells and is a nonspecific finding. The term \"reduced poikilocytosis\" is not typically used to describe findings in anemia.</li><li>\u2022 Option C. Poikilocytosis</li><li>\u2022 abnormally shaped red blood cells</li><li>\u2022 nonspecific finding.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When evaluating a patient with anemia, particularly in the setting of fatigue and dyspnea on exertion with a significantly low hemoglobin level , finding microcytic and hypochromic red cells on the peripheral blood smear strongly suggests iron deficiency anemia .</li><li>\u27a4 fatigue and dyspnea on exertion</li><li>\u27a4 low hemoglobin level</li><li>\u27a4 microcytic and hypochromic red cells</li><li>\u27a4 iron deficiency anemia</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "01e7fb4e",
      "audio": ""
    },
    {
      "text": "A 52-year-old male presents with fatigue, light-headedness, and a beefy-red tongue. Laboratory tests show macrocytosis and hypersegmented neutrophils. Which of the following laboratory findings is inconsistent with untreated megaloblastic anemia?",
      "options": [
        {
          "label": "A",
          "text": "Increased reticulocyte count",
          "correct": true
        },
        {
          "label": "B",
          "text": "Raised Bilirubin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mild splenomegaly",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nucleated RBC",
          "correct": false
        }
      ],
      "correct_answer": "A. Increased reticulocyte count",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Increased reticulocyte count</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Raised bilirubin levels can be seen in megaloblastic anemia due to increased destruction of defective erythroid precursor cells in the bone marrow, which release bilirubin into the blood.</li><li>\u2022 Option B. Raised bilirubin</li><li>\u2022 megaloblastic anemia</li><li>\u2022 increased destruction of defective erythroid precursor</li><li>\u2022 cells in the bone marrow,</li><li>\u2022 bilirubin</li><li>\u2022 Option C. Mild splenomegaly may be observed in megaloblastic anemia as the spleen works to filter the abnormal cells from the bloodstream.</li><li>\u2022 Option C. Mild splenomegaly</li><li>\u2022 megaloblastic anemia</li><li>\u2022 filter the abnormal cells</li><li>\u2022 bloodstream.</li><li>\u2022 Option D. The presence of nucleated RBCs in the peripheral blood smear is a sign of severe anemia , including megaloblastic anemia , where immature and abnormal erythroid precursor cells are released into the bloodstream.</li><li>\u2022 Option D. The presence</li><li>\u2022 nucleated RBCs</li><li>\u2022 severe anemia</li><li>\u2022 megaloblastic anemia</li><li>\u2022 immature and abnormal erythroid precursor cells</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 in untreated megaloblastic anemia , the reticulocyte count is low due to impaired DNA synthesis and ineffective erythropoiesis. An increased reticulocyte count after initiating treatment with vitamin B12 and folate supplementation indicates a positive response to therapy.</li><li>\u27a4 untreated megaloblastic anemia</li><li>\u27a4 reticulocyte count is low due to impaired DNA synthesis</li><li>\u27a4 ineffective erythropoiesis.</li><li>\u27a4 increased reticulocyte count</li><li>\u27a4 vitamin B12 and folate supplementation</li><li>\u27a4 Ref : Robbins 10 th / 645, Wintrobe\u2019s 12th/1151-3</li><li>\u27a4 Ref : Robbins 10 th / 645, Wintrobe\u2019s 12th/1151-3</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c45e129",
      "audio": ""
    },
    {
      "text": "A 52-year-old male with a history of strict vegetarianism presents with weakness and paresthesias. A CBC shows macrocytosis, and his serum vitamin B12 level is low. Which of the following is most consistent with the pathophysiology of his condition?",
      "options": [
        {
          "label": "A",
          "text": "Microcytic hypochromic anemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sickled red cells",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anemia occurs after 3-4 years of poor absorption",
          "correct": true
        },
        {
          "label": "D",
          "text": "Development of polycythemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Anemia occurs after 3-4 years of poor absorption",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Anemia occurs after 3-4 years of poor absorption</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Microcytic hypochromic anemia is typically associated with iron deficiency, thalassemia, or other disorders of hemoglobin synthesis, not with vitamin B12 deficiency .</li><li>\u2022 Option A.</li><li>\u2022 Microcytic hypochromic anemia</li><li>\u2022 iron deficiency, thalassemia,</li><li>\u2022 hemoglobin synthesis,</li><li>\u2022 vitamin B12 deficiency</li><li>\u2022 Option B. Sickled red cells are characteristic of sickle cell anemia , a genetic disorder caused by a mutation in the hemoglobin gene , not related to vitamin B12 absorption.</li><li>\u2022 Option B.</li><li>\u2022 Sickled red cells</li><li>\u2022 sickle cell anemia</li><li>\u2022 genetic disorder</li><li>\u2022 mutation in the hemoglobin gene</li><li>\u2022 Option D. Polycythemia refers to an increased concentration of hemoglobin in the blood , typically not related to vitamin B12 deficiency. Instead, vitamin B12 deficiency would lead to a decrease in red cell production due to maturation failure .</li><li>\u2022 Option D.</li><li>\u2022 Polycythemia</li><li>\u2022 increased concentration of hemoglobin in the blood</li><li>\u2022 vitamin B12 deficiency</li><li>\u2022 decrease in red cell production</li><li>\u2022 maturation failure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When considering a diagnosis of megaloblastic anemia due to vitamin B12 deficiency, significant hepatic stores of vitamin B12 can delay the onset of anemia for several years in patients with poor dietary intake .</li><li>\u27a4 megaloblastic anemia due to vitamin B12 deficiency,</li><li>\u27a4 hepatic stores of vitamin B12</li><li>\u27a4 delay the onset of anemia for several years</li><li>\u27a4 poor dietary intake</li><li>\u27a4 Ref : Robbins 10 th / 651-2</li><li>\u27a4 Ref : Robbins 10 th / 651-2</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ae174892",
      "audio": ""
    },
    {
      "text": "A 32-year-old female presents with fatigue, weakness, and shortness of breath. Laboratory investigations reveal macrocytic anemia, and the FIGLU test is conducted to assess the etiology. FIGLU test is done for:",
      "options": [
        {
          "label": "A",
          "text": "Cyanocobalamin deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folic acid deficiency",
          "correct": true
        },
        {
          "label": "C",
          "text": "Thiamine deficiency",
          "correct": false
        },
        {
          "label": "D",
          "text": "Riboflavin deficiency",
          "correct": false
        }
      ],
      "correct_answer": "B. Folic acid deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Folic acid deficiency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Vitamin B12 deficiency can lead to macrocytic anemia and is usually confirmed by low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels , not typically with a FIGLU test.</li><li>\u2022 Option A. Vitamin B12</li><li>\u2022 macrocytic anemia</li><li>\u2022 low serum levels of B12 or elevated serum methylmalonic acid and homocysteine levels</li><li>\u2022 Option C. Deficiency of thiamine leads to conditions like beriberi or Wernicke-Korsakoff syndrome , not typically associated with macrocytic anemia or a positive FIGLU test.</li><li>\u2022 Option C. Deficiency</li><li>\u2022 thiamine</li><li>\u2022 beriberi or Wernicke-Korsakoff syndrome</li><li>\u2022 Option D. Riboflavin deficiency is associated with symptoms such as angular stomatitis and glossitis, but not usually with macrocytic anemia, and it does not cause elevated FIGLU levels.</li><li>\u2022 Option D. Riboflavin</li><li>\u2022 angular stomatitis and glossitis,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with unexplained macrocytic anemia, a positive FIGLU test in the urine indicates a deficiency in folate . FIGLU is a biomarker for intracellular levels of folate .</li><li>\u27a4 unexplained macrocytic anemia,</li><li>\u27a4 positive FIGLU test</li><li>\u27a4 deficiency in folate</li><li>\u27a4 biomarker</li><li>\u27a4 for</li><li>\u27a4 intracellular levels of folate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "723579de",
      "audio": ""
    },
    {
      "text": "A 24-year-old woman presents with mild anemia noted on routine screening. She reports a family history of anemia but has no significant personal medical history. She denies any symptoms of anemia. A hemoglobin electrophoresis is performed, showing an increased HbA2 level. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Beta thalassemia trait",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hereditory spherocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "G6 PD deficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Beta thalassemia trait",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Beta thalassemia trait</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sickle cell anemia is characterized by a mutation in the beta-globin gene that leads to the production of hemoglobin S. Hemoglobin electrophoresis in sickle cell anemia typically shows a predominance of HbS and possibly elevated HbF but not HbA2.</li><li>\u2022 Option B. Sickle cell anemia</li><li>\u2022 Option C. Hereditary spherocytosis is a disorder of the red blood cell membrane leading to spherical erythrocytes and hemolytic anemia. It does not involve abnormalities in hemoglobin synthesis or elevated HbA2 levels.</li><li>\u2022 Option C. Hereditary spherocytosis</li><li>\u2022 Option D. G6PD deficiency is an X-linked enzymatic defect leading to hemolytic anemia under conditions of oxidative stress. It is not associated with an increase in HbA2 on electrophoresis.</li><li>\u2022 Option D. G6PD deficiency</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When a hemoglobin electrophoresis reveals increased HbA2 levels, it is indicative of beta thalassemia trait, reflecting an imbalance in globin chain production.</li><li>\u27a4 Ref : Robbins 10 th / 641</li><li>\u27a4 Ref : Robbins 10 th / 641</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f11e4ce",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT a clinical presentation feature of paroxysmal nocturnal hemoglobinuria?",
      "options": [
        {
          "label": "A",
          "text": "Thrombosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Leukemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Aplastic anemia \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hemolysis \u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "B. Leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Leukemi</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Thrombosis, particularly in unusual sites such as the hepatic or cerebral veins , is a well-recognized complication of paroxysmal nocturnal hemoglobinuria (PNH) due to the increased propensity for red blood cells to activate the complement system and the coagulation cascade .</li><li>\u2022 Option A. Thrombosis,</li><li>\u2022 hepatic or cerebral veins</li><li>\u2022 of paroxysmal nocturnal hemoglobinuria (PNH)</li><li>\u2022 increased propensity for red blood cells</li><li>\u2022 complement system and the coagulation cascade</li><li>\u2022 Option C. Aplastic anemia can be a presenting feature of PNH due to the associated bone marrow failure that can occur with the disease process.</li><li>\u2022 Option C. Aplastic anemia</li><li>\u2022 PNH due to the associated bone marrow failure</li><li>\u2022 Option D. Intravascular hemolysis is a hallmark of PNH , caused by the increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins that normally protect the cell membrane from complement activation .</li><li>\u2022 Option D. Intravascular hemolysis</li><li>\u2022 hallmark of PNH</li><li>\u2022 increased sensitivity of red blood cells to complement due to a deficiency in GPI-anchored proteins</li><li>\u2022 cell membrane from complement activation</li><li>\u2022 ducational Objective:</li><li>\u2022 ducational Objective:</li><li>\u2022 PNH is characterized by hemolytic anemia, pancytopenia, and thrombosis , but leukemia is not a feature of PNH but may be a secondary complication of the disease.</li><li>\u2022 PNH</li><li>\u2022 hemolytic anemia, pancytopenia, and thrombosis</li><li>\u2022 leukemia is not a feature of PNH</li><li>\u2022 secondary complication</li><li>\u2022 Ref : Robbins 10th/e p648</li><li>\u2022 Ref : Robbins 10th/e p648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fcc1a4ed",
      "audio": ""
    },
    {
      "text": "A 55-year-old male presents with fatigue, weakness, and pallor. Laboratory investigations reveal a microcytic, hypochromic anemia. Peripheral blood smear shows microcytic red blood cells, and bone marrow biopsy confirms the presence of ringed sideroblasts. The patient does not have a history of significant alcohol consumption. Which of the following treatments is most likely to improve the anemia in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Iron \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        },
        {
          "label": "B",
          "text": "B1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pyridoxine",
          "correct": true
        },
        {
          "label": "D",
          "text": "B12",
          "correct": false
        }
      ],
      "correct_answer": "C. Pyridoxine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Pyridoxine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. iron supplementation is used for iron deficiency anemia, which typically does not feature ringed sideroblasts. In sideroblastic anemia , there is usually adequate or increased iron in the body , but it's not properly incorporated into hemoglobin.</li><li>\u2022 Option A. iron supplementation is used</li><li>\u2022 iron deficiency anemia,</li><li>\u2022 sideroblastic anemia</li><li>\u2022 adequate or increased iron in the body</li><li>\u2022 Option B.Thiamine deficiency does not typically cause sideroblastic anemia , so supplementation would not address the underlying pathophysiology in this case.</li><li>\u2022 Option B.Thiamine deficiency</li><li>\u2022 does not</li><li>\u2022 sideroblastic anemia</li><li>\u2022 would not address</li><li>\u2022 pathophysiology</li><li>\u2022 Option D. Vitamin B12 deficiency causes megaloblastic anemia , not typically sideroblastic anemia, so this would not be the treatment of choice for a patient with ringed sideroblasts .</li><li>\u2022 Option D. Vitamin B12 deficiency</li><li>\u2022 megaloblastic anemia</li><li>\u2022 sideroblastic anemia,</li><li>\u2022 not be the</li><li>\u2022 treatment of choice</li><li>\u2022 ringed sideroblasts</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sideroblastic anemia can be responsive to pyridoxine supplementation, especially when ringed sideroblasts are observed on bone marrow biopsy and the patient does not have a history of conditions that could cause secondary sideroblastic anemia , such as alcoholism or lead poisoning.</li><li>\u27a4 Sideroblastic anemia</li><li>\u27a4 pyridoxine supplementation,</li><li>\u27a4 ringed sideroblasts</li><li>\u27a4 bone marrow biopsy</li><li>\u27a4 does not</li><li>\u27a4 cause secondary sideroblastic anemia</li><li>\u27a4 alcoholism or lead poisoning.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "502b542c",
      "audio": ""
    },
    {
      "text": "A 30-year-old African American male presents to the emergency room with jaundice and dark urine after taking a sulfa drug for a urinary tract infection. He has a past medical history of a similar episode after eating fava beans. His labs reveal hemolytic anemia. Which of the following is NOT a consequence of the enzyme deficiency this patient most likely has?",
      "options": [
        {
          "label": "A",
          "text": "Decrease in reduced glutathione",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease in NADPH",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increased in lipid peroxidation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased RBC membrane damage \u200b\u200b\u200b",
          "correct": true
        }
      ],
      "correct_answer": "D. Decreased RBC membrane damage \u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Decreased RBC membrane damage</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. In G6PD deficiency , there is a decrease in reduced glutathione due to insufficient NADPH , leading to decreased ability to neutralize oxidative stress in red blood cells.</li><li>\u2022 Option A. In G6PD deficiency</li><li>\u2022 decrease in reduced glutathione</li><li>\u2022 insufficient NADPH</li><li>\u2022 decreased ability to neutralize oxidative stress</li><li>\u2022 Option B. G6PD deficiency results in a decrease in NADPH production , a critical factor in maintaining the reduced state of glutathione.</li><li>\u2022 Option B. G6PD deficiency</li><li>\u2022 decrease in NADPH production</li><li>\u2022 reduced state of glutathione.</li><li>\u2022 Option C. Without enough reduced glutathione , red blood cells are more susceptible to oxidative stress , leading to increased lipid peroxidation and membrane damage .</li><li>\u2022 Option C. Without enough</li><li>\u2022 reduced glutathione</li><li>\u2022 more susceptible to oxidative stress</li><li>\u2022 lipid peroxidation and membrane damage</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Decreased red blood cell membrane damage is not associated with G6PD deficiency.</li><li>\u27a4 Decreased red blood cell membrane</li><li>\u27a4 not</li><li>\u27a4 G6PD deficiency.</li><li>\u27a4 Ref : Robbins 10th/e p640</li><li>\u27a4 Ref : Robbins 10th/e p640</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0c130e54",
      "audio": ""
    },
    {
      "text": "A 20-year-old female presents with the following laboratory values: hemoglobin 9gm%, MCV is 55%, RBC is 4.5 million/mm3. There is no history of blood transfusion. What is the most likely diagnosis out of the following?",
      "options": [
        {
          "label": "A",
          "text": "Thalassemia major",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thalassemia minor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Iron deficiency anemia \u200b",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anemia of chronic disease",
          "correct": false
        }
      ],
      "correct_answer": "B. Thalassemia minor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Thalassemia minor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Patients with thalassemia major typically present with severe anemia requiring regular blood transfusions. The degree of anemia in the vignette is not consistent with thalassemia major.</li><li>\u2022 Option A. Patients with thalassemia</li><li>\u2022 major</li><li>\u2022 severe anemia</li><li>\u2022 blood transfusions.</li><li>\u2022 vignette</li><li>\u2022 Option C. Iron deficiency anemia typically presents with microcytic and hypochromic anemia . The Mentzer index is generally greater than 13 , which is not the case here.</li><li>\u2022 Option C. Iron deficiency anemia</li><li>\u2022 microcytic and hypochromic anemia</li><li>\u2022 Mentzer index</li><li>\u2022 greater than 13</li><li>\u2022 Option D. Anemia of chronic disease usually presents with normocytic or sometimes microcytic anemia , but it is often characterized by a normal or increased storage iron level , which can be evaluated by serum ferritin.</li><li>\u2022 Option D. Anemia of chronic disease</li><li>\u2022 normocytic or sometimes microcytic anemia</li><li>\u2022 normal or increased storage iron level</li><li>\u2022 serum ferritin.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When presented with mild to moderate microcytic anemia and an MCV/RBC count that yields a Mentzer index of less than 13, thalassemia minor is a likely diagnosis.</li><li>\u27a4 mild to moderate microcytic anemia</li><li>\u27a4 MCV/RBC count</li><li>\u27a4 Mentzer index of less than 13, thalassemia minor</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa347cfb",
      "audio": ""
    },
    {
      "text": "The pathogenesis of hypochromic anemia in lead poisoning is due to:",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of enzymes involved in heme biosynthesis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Binding of lead to transferrin, inhibiting the trans\u00adport of iron",
          "correct": false
        },
        {
          "label": "C",
          "text": "Binding of lead to cell membrane of erythroid pre\u00adcursors.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Binding of lead to ferritin inhibiting their break\u00addown into hemosiderin",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of enzymes involved in heme biosynthesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Inhibition of enzymes involved in heme bio\u00adsynthesis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Lead does not bind to transferrin directly</li><li>\u2022 Option B. Lead</li><li>\u2022 Option C. While lead can affect cell membrane s, the primary mechanism of hypochromic anemia in lead poisoning is related to its impact on enzymes involved in heme biosynthesis, not direct binding to cell membranes.</li><li>\u2022 Option C. While lead can affect</li><li>\u2022 cell membrane</li><li>\u2022 hypochromic anemia</li><li>\u2022 enzymes involved in heme biosynthesis,</li><li>\u2022 Option D. Lead does not directly bind to ferritin to inhibit their breakdown. The primary effect is on heme synthesis enzymes.</li><li>\u2022 Option D. Lead does not directly</li><li>\u2022 ferritin to inhibit their breakdown.</li><li>\u2022 heme synthesis enzymes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The primary pathogenesis of hypochromic anemia in lead poisoning involves the inhibition of enzymes necessary for heme biosynthesis , such as aminolevulinic acid dehydratase (ALAD) and ferrochelatase, leading to reduced heme and hemoglobin production.</li><li>\u27a4 hypochromic anemia in lead poisoning</li><li>\u27a4 inhibition of enzymes necessary</li><li>\u27a4 heme biosynthesis</li><li>\u27a4 aminolevulinic acid dehydratase (ALAD) and ferrochelatase,</li><li>\u27a4 heme and hemoglobin production.</li><li>\u27a4 Ref : Robbins 10 th / 411, Tejinder Singh 1st/147</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 411, Tejinder Singh 1st/147</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "871b1073",
      "audio": ""
    },
    {
      "text": "A 50-year-old male is evaluated for anemia. Laboratory findings reveal increased serum ferritin, decreased total iron-binding capacity (TIBC), increased serum iron, and elevated transferrin saturation. Which of the following is the most likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Anemia of chronic disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sideroblastic anemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Iron deficiency anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Thalassemia minor",
          "correct": false
        }
      ],
      "correct_answer": "B. Sideroblastic anemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Anemia of chronic disease - Typically presents with normal to increased serum ferritin , normal to decreased serum iron, and low transferrin saturation due to the sequestration of iron in macrophages .</li><li>\u2022 Option A. Anemia of chronic disease</li><li>\u2022 normal to increased serum ferritin</li><li>\u2022 normal to decreased serum iron, and low transferrin saturation</li><li>\u2022 sequestration of iron in macrophages</li><li>\u2022 Option C. Iron deficiency anemia - Manifests with decreased serum ferritin, increased TIBC, decreased serum iron, and low transferrin saturation due to a lack of iron stores.</li><li>\u2022 Option C. Iron deficiency anemia</li><li>\u2022 decreased serum ferritin, increased TIBC, decreased serum iron, and low</li><li>\u2022 transferrin saturation</li><li>\u2022 lack of iron stores.</li><li>\u2022 Option D. Thalassemia minor - This condition usually presents with normal iron studies and is characterized by microcytic red blood cells without an increase in iron parameters.</li><li>\u2022 Option D. Thalassemia minor</li><li>\u2022 normal iron studies</li><li>\u2022 microcytic red blood cells</li><li>\u2022 increase in iron parameters.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sideroblastic anemia is indicated by increased serum ferritin , decreased TIBC, increased serum iron, and elevated transferrin saturation , reflecting a defect in the incorporation of iron into hemoglobin within the erythroid precursors in the bone marrow .</li><li>\u27a4 Sideroblastic anemia</li><li>\u27a4 increased serum ferritin</li><li>\u27a4 decreased TIBC, increased serum iron, and elevated transferrin saturation</li><li>\u27a4 iron into hemoglobin</li><li>\u27a4 erythroid precursors in the bone marrow</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a118bcfd",
      "audio": ""
    },
    {
      "text": "A 58-year-old man with a history of rheumatoid arthritis presents with fatigue and exertional dyspnea. Laboratory tests show a mild anemia with a hemoglobin of 10 g/dL. Further workup reveals the following: serum ferritin is elevated, total iron-binding capacity (TIBC) is decreased, serum iron is reduced, and transferrin saturation percentage is decreased. Which laboratory finding is most characteristic of the anemia of chronic disease?",
      "options": [
        {
          "label": "A",
          "text": "TIBC \u2191",
          "correct": false
        },
        {
          "label": "B",
          "text": "S. Iron \u2191",
          "correct": false
        },
        {
          "label": "C",
          "text": "BM iron \u2193",
          "correct": false
        },
        {
          "label": "D",
          "text": "S. ferritin \u2191",
          "correct": true
        }
      ],
      "correct_answer": "D. S. ferritin \u2191",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. S. ferritin \u2191</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. TIBC is typically increased due to the body's attempt to increase iron binding capacity in response to low iron stores , which is not the case in anemia of chronic disease.</li><li>\u2022 Option A. TIBC is typically</li><li>\u2022 increased</li><li>\u2022 increase iron binding capacity</li><li>\u2022 low iron stores</li><li>\u2022 Option B. Anemia of chronic disease typically presents with decreased serum iron due to sequestration of iron within macrophages and hepatocytes .</li><li>\u2022 Option B. Anemia of chronic disease</li><li>\u2022 decreased serum iron due to sequestration of iron</li><li>\u2022 macrophages and hepatocytes</li><li>\u2022 Option C. In anemia of chronic disease , bone marrow iron stores are usually normal or increased , not decreased.</li><li>\u2022 Option C. In anemia of chronic disease</li><li>\u2022 iron stores</li><li>\u2022 normal or increased</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most characteristic laboratory finding in anemia of chronic disease is increased serum ferritin, reflecting sequestered iron stores that are not available for effective erythropoiesis despite the body having adequate or increased total iron.</li><li>\u27a4 anemia of chronic disease</li><li>\u27a4 increased serum ferritin,</li><li>\u27a4 sequestered iron stores</li><li>\u27a4 effective erythropoiesis despite the body</li><li>\u27a4 adequate or increased total iron.</li><li>\u27a4 Robbins 10 th / 659</li><li>\u27a4 Robbins 10 th / 659</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "99f3c466",
      "audio": ""
    },
    {
      "text": "A 12-year-old with history of recurrent infection and bleeding gums. On investigations the patient had pancytopenia and the peripheral smear showed macrocytes. The bone marrow biopsy showed no megakaryocytes and filled with fat globules. What is your diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Myelodysplasia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aplastic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": true
        },
        {
          "label": "C",
          "text": "ITP",
          "correct": false
        },
        {
          "label": "D",
          "text": "PNH",
          "correct": false
        }
      ],
      "correct_answer": "B. Aplastic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Aplastic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The given clinical presentation of a 12-year-old with recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow, and the presence of fat globules in the bone marrow biopsy is suggestive of aplastic anemia. Aplastic anemia is characterized by a deficiency of all blood cell types (pancytopenia) due to bone marrow failure . The absence of megakaryocytes in the bone marrow biopsy indicates a lack of platelet precursors, which can lead to bleeding manifestations . The presence of fat globules suggests replacement of hematopoietic cells by adipose tissue in the bone marrow.</li><li>\u2022 12-year-old</li><li>\u2022 recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral</li><li>\u2022 smear, absence of megakaryocytes in bone marrow,</li><li>\u2022 presence of fat globules</li><li>\u2022 aplastic anemia.</li><li>\u2022 Aplastic anemia</li><li>\u2022 deficiency of all blood cell types (pancytopenia)</li><li>\u2022 bone marrow failure</li><li>\u2022 absence of megakaryocytes</li><li>\u2022 lack of platelet precursors,</li><li>\u2022 bleeding manifestations</li><li>\u2022 fat globules</li><li>\u2022 hematopoietic cells by adipose tissue</li><li>\u2022 EXPLANATION:</li><li>\u2022 EXPLANATION:</li><li>\u2022 Option A. Myelodysplastic syndromes : may also present with cytopenias and dysplastic changes in the bone marrow, but the absence of megakaryocytes and the presence of fat globules are not typical features.</li><li>\u2022 Option A. Myelodysplastic syndromes :</li><li>\u2022 cytopenias and dysplastic</li><li>\u2022 absence of megakaryocytes</li><li>\u2022 presence of fat globules are not typical features.</li><li>\u2022 Option C. ITP: is characterized by isolated thrombocytopenia without affecting other cell lines. It does not typically present with pancytopenia or the absence of megakaryocytes in the bone marrow.</li><li>\u2022 Option C. ITP:</li><li>\u2022 isolated thrombocytopenia</li><li>\u2022 Option D. PNH: is characterized by hemolysis, often presenting with hemoglobinuria. However, it is not typically associated with pancytopenia and fat globules in the bone marrow.</li><li>\u2022 Option D. PNH:</li><li>\u2022 hemolysis,</li><li>\u2022 hemoglobinuria.</li><li>\u2022 not typically</li><li>\u2022 pancytopenia and fat globules in the bone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The clinical presentation of recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow , and presence of fat globules in bone marrow biopsy is indicative of aplastic anemia . This diagnosis is supported by the bone marrow biopsy findings showing a lack of megakaryocytes, indicative of platelet precursor deficiency, and fat globules suggesting the replacement of hematopoietic cells by adipose tissue .</li><li>\u27a4 recurrent infections, bleeding gums, pancytopenia, macrocytes on peripheral smear, absence of megakaryocytes in bone marrow</li><li>\u27a4 presence of fat globules</li><li>\u27a4 aplastic anemia</li><li>\u27a4 bone marrow biopsy</li><li>\u27a4 lack of megakaryocytes, indicative of platelet precursor deficiency,</li><li>\u27a4 fat globules</li><li>\u27a4 hematopoietic cells by adipose tissue</li><li>\u27a4 Ref : Robbins 10th/458</li><li>\u27a4 Ref : Robbins 10th/458</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96a4b6a1",
      "audio": ""
    },
    {
      "text": "An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bronchogenic cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thymoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Non-Hodgkin lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Squamous cell carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Thymoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Thymoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bronchogenic cancer often presents as a mediastinal mass , especially in smokers . However, it is not commonly associated with red cell aplasia, but rather with other paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.</li><li>\u2022 Option A. Bronchogenic cancer</li><li>\u2022 mediastinal mass</li><li>\u2022 smokers</li><li>\u2022 paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.</li><li>\u2022 Option C. Non-Hodgkin lymphoma can present as a mediastinal mass . It may cause bone marrow involvement leading to various cytopenias but is not specifically associated with pure red cell aplasia .</li><li>\u2022 Option C. Non-Hodgkin lymphoma</li><li>\u2022 mediastinal mass</li><li>\u2022 bone marrow</li><li>\u2022 cytopenias</li><li>\u2022 not</li><li>\u2022 pure red cell aplasia</li><li>\u2022 Option D. Squamous cell carcinoma typically arises from the epithelial cells of the skin or mucous membranes and is not commonly found within the mediastinum. It is associated with paraneoplastic syndromes , but not typically with red cell aplasia.</li><li>\u2022 Option D. Squamous cell carcinoma</li><li>\u2022 epithelial cells of the skin or mucous membranes</li><li>\u2022 paraneoplastic syndromes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thymoma is the likely diagnosis in an elderly patient with a mediastinal mass and red cell aplasia, as thymomas are associated with this condition and other paraneoplastic syndromes such as myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.</li><li>\u27a4 Thymoma</li><li>\u27a4 mediastinal mass and red cell aplasia, as thymomas</li><li>\u27a4 paraneoplastic syndromes</li><li>\u27a4 myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.</li><li>\u27a4 Ref : Robbins 10th/e p493</li><li>\u27a4 Ref : Robbins 10th/e p493</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bf00069",
      "audio": ""
    },
    {
      "text": "A patient has been eating junk food regularly for few months and avoids fruits and vegetables. His hemoglobin is 9 g/dl and MCV is >125 fl. What is the deficiency she would likely be having?",
      "options": [
        {
          "label": "A",
          "text": "Cyanocobalamin deficiency",
          "correct": false
        },
        {
          "label": "B",
          "text": "Folate deficiency",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sideroblastic anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute blood loss",
          "correct": false
        }
      ],
      "correct_answer": "B. Folate deficiency",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Folate deficiency</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cyanocobalamin (Vitamin B12) deficiency typically develops over years due to the substantial stores in the liver . While it can cause megaloblastic anemia with a high MCV, the patient's short history of symptoms makes this less likely.</li><li>\u2022 Option A. Cyanocobalamin (Vitamin B12)</li><li>\u2022 deficiency</li><li>\u2022 over years due to the substantial stores in the liver</li><li>\u2022 megaloblastic anemia</li><li>\u2022 high MCV,</li><li>\u2022 Option C. Sideroblastic anemia is characterized by the presence of ringed sideroblasts in the bone marrow and can be associated with certain drugs and toxins, genetic disorders , or may be idiopathic . It doesn't typically relate directly to dietary habits and usually shows a normal or increased MCV but not typically in the megaloblastic range (>100 fL).</li><li>\u2022 Option C. Sideroblastic anemia</li><li>\u2022 ringed sideroblasts</li><li>\u2022 drugs and toxins, genetic disorders</li><li>\u2022 idiopathic</li><li>\u2022 Option D. Acute blood loss would cause anemia with a low or normal MCV (microcytic or normocytic), not the high MCV (>100 fL) that is typical of megaloblastic anemias. Plus, there is no history suggestive of blood loss.</li><li>\u2022 Option D. Acute blood loss would cause anemia</li><li>\u2022 low or normal MCV (microcytic or normocytic),</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Folate deficiency is the likely cause of megaloblastic anemia with a high MCV in a patient with a diet lacking in fruits and vegetables and a relatively quick onset of symptoms , as folate stores are depleted much more rapidly than vitamin B12 stores .</li><li>\u27a4 Folate deficiency</li><li>\u27a4 megaloblastic anemia</li><li>\u27a4 high MCV</li><li>\u27a4 fruits and vegetables and a relatively quick onset of symptoms</li><li>\u27a4 folate stores are depleted much more rapidly than vitamin B12 stores</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cdd95845",
      "audio": ""
    },
    {
      "text": "Which of the following test best differentiates cobalamin and folate deficiency?",
      "options": [
        {
          "label": "A",
          "text": "Plasma homocysteine levels",
          "correct": false
        },
        {
          "label": "B",
          "text": "Peripheral smear showing megaloblasts",
          "correct": false
        },
        {
          "label": "C",
          "text": "High value of mean cell volume",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serum methylmalonic acid levels",
          "correct": true
        }
      ],
      "correct_answer": "D. Serum methylmalonic acid levels",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Serum methylmalonic acid levels</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Plasma homocysteine levels are elevated in both cobalamin (vitamin B12) and folate deficiencies, as both vitamins are involved in the metabolism of homocysteine . Therefore, it does not differentiate between the two.</li><li>\u2022 Option A. Plasma homocysteine levels</li><li>\u2022 elevated</li><li>\u2022 cobalamin (vitamin B12) and folate deficiencies,</li><li>\u2022 metabolism of homocysteine</li><li>\u2022 Option B. Peripheral smear showing megaloblasts is a feature common to both cobalamin and folate deficiencies , as both lead to impaired DNA synthesis and resultant megaloblastic anemia.</li><li>\u2022 Option B. Peripheral smear</li><li>\u2022 megaloblasts</li><li>\u2022 cobalamin and folate deficiencies</li><li>\u2022 impaired DNA synthesis and resultant megaloblastic anemia.</li><li>\u2022 Option C. A high mean cell volume (MCV) is indicative of macrocytic anemia , which can result from either cobalamin or folate deficiency . This finding is not specific to either condition.</li><li>\u2022 Option C. A high mean cell volume</li><li>\u2022 macrocytic anemia</li><li>\u2022 either cobalamin or folate deficiency</li><li>\u2022 not specific</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Serum methylmalonic acid levels is one of diagnostic test that differentiates between cobalamin and folate deficiencies, since it is increased in cobalamin deficiency but remains normal in folate deficiency.</li><li>\u27a4 Serum methylmalonic acid</li><li>\u27a4 diagnostic test</li><li>\u27a4 cobalamin and folate deficiencies,</li><li>\u27a4 increased in cobalamin deficiency</li><li>\u27a4 normal in folate deficiency.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "813d0f92",
      "audio": ""
    },
    {
      "text": "A 25-year-old male is undergoing workup for fatigue and joint pain. His serum ferritin levels are markedly elevated, and a liver biopsy shows iron deposition. Which of the following most directly regulates iron uptake in the gut?",
      "options": [
        {
          "label": "A",
          "text": "Mucosal cell iron stores",
          "correct": true
        },
        {
          "label": "B",
          "text": "Route of administration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Preparation administered",
          "correct": false
        },
        {
          "label": "D",
          "text": "Age of the patient",
          "correct": false
        }
      ],
      "correct_answer": "A. Mucosal cell iron stores",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Mucosal cell iron stores</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. The route of administration, such as oral or parenteral , can influence the rate of iron absorption but does not directly regulate iron uptake at the molecular level .</li><li>\u2022 Option B. The route of administration,</li><li>\u2022 oral or parenteral</li><li>\u2022 iron absorption</li><li>\u2022 iron uptake at the molecular level</li><li>\u2022 Option C. The preparation administered , for example, ferrous sulfate versus ferric gluconate , can affect the efficiency of absorption but , like the route, does not regulate the iron uptake process per se.</li><li>\u2022 Option C. The preparation administered</li><li>\u2022 ferrous sulfate versus ferric gluconate</li><li>\u2022 efficiency of absorption but</li><li>\u2022 does not regulate the iron uptake process</li><li>\u2022 Option D. The age of the patient can affect the demand for iron , especially during growth spurts or aging , but it is not a direct regulator of iron uptake in the gut.</li><li>\u2022 Option D. The age of the patient</li><li>\u2022 demand for iron</li><li>\u2022 growth spurts or aging</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mucosal cell iron stores , through their regulation of hepcidin synthesis, play a direct role in regulating iron uptake across the gut mucosa , which is crucial for maintaining systemic iron homeostasis .</li><li>\u27a4 Mucosal cell iron stores</li><li>\u27a4 hepcidin synthesis,</li><li>\u27a4 regulating iron uptake</li><li>\u27a4 gut mucosa</li><li>\u27a4 systemic iron homeostasis</li><li>\u27a4 Ref : Robbins 10 th / 658</li><li>\u27a4 Ref</li><li>\u27a4 Robbins 10 th / 658</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bbf85a59",
      "audio": ""
    },
    {
      "text": "A 45-year-old male with a history of hereditary hemochromatosis is being evaluated for his condition. Which of the following is considered the most important but nonspecific regulator of iron metabolism?",
      "options": [
        {
          "label": "A",
          "text": "Hepcidin",
          "correct": true
        },
        {
          "label": "B",
          "text": "DMT1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ferroportin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ferritin",
          "correct": false
        }
      ],
      "correct_answer": "A. Hepcidin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Hepcidin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. DMT1 (Divalent metal transporter 1) is a specific transporter that moves ferrous iron across the apical membrane of enterocytes. While important for iron uptake, it has a more focused role.</li><li>\u2022 Option B. DMT1</li><li>\u2022 Option C. Ferroportin is the protein responsible for exporting iron from cells into the plasma. It has a specific function and is regulated by hepcidin.</li><li>\u2022 Option C. Ferroportin</li><li>\u2022 Option D. Ferritin is the primary intracellular iron storage protein and is a marker of iron stores but does not regulate iron metabolism directly.</li><li>\u2022 Option D. Ferritin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepcidin is the most important but nonspecific regulator of iron metabolism since it not only controls iron homeostasis but also has broader effects including antimicrobial activity and is influenced by various physiological and pathological conditions.</li><li>\u27a4 Ref: Robbins 10th/ 652</li><li>\u27a4 Ref: Robbins 10th/ 652</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "96787206",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents with dark urine in the morning and has been found to have hemolytic anemia on laboratory evaluation. A diagnostic test reveals increased sensitivity of his red blood cells to lysis in acidified serum. Which of the following underlying defects is most consistent with these findings?",
      "options": [
        {
          "label": "A",
          "text": "Spectrin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Defect in complement activating proteins",
          "correct": false
        },
        {
          "label": "C",
          "text": "Defective GPI anchor",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mannose-binding residue effect",
          "correct": false
        }
      ],
      "correct_answer": "C. Defective GPI anchor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. \u00a0Defective GPI anchor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Spectrin is a cytoskeletal protein that helps maintain the red blood cell's shape . Defects in spectrin can cause hereditary spherocytosis but are not associated with increased red cell lysis in acidified serum.</li><li>\u2022 Option A. Spectrin is a cytoskeletal protein</li><li>\u2022 red blood cell's shape</li><li>\u2022 hereditary spherocytosis</li><li>\u2022 Option B. A defect in complement activating proteins may lead to conditions such as hereditary angioedema , but they do not result in the increased red cell lysis characteristic of the Ham test.</li><li>\u2022 Option B. A defect in complement</li><li>\u2022 hereditary angioedema</li><li>\u2022 Option D. The Mannose-binding lectin pathway is involved in innate immunity and can lead to opsonization and phagocytosis of pathogens, but defects here do not lead to the clinical picture described.</li><li>\u2022 Option D. The Mannose-binding lectin</li><li>\u2022 innate immunity</li><li>\u2022 opsonization and phagocytosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A defective GPI anchor is implicated in paroxysmal nocturnal hemoglobinuria (PNH), a condition that can be diagnosed with the Ham test , indicating increased red blood cell lysis in acidified serum due to increased complement sensitivity.</li><li>\u27a4 defective GPI anchor</li><li>\u27a4 paroxysmal nocturnal hemoglobinuria (PNH),</li><li>\u27a4 Ham test</li><li>\u27a4 increased red blood cell lysis</li><li>\u27a4 increased complement sensitivity.</li><li>\u27a4 Ref : Robbins 10 th / 645</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 645</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3530ee9",
      "audio": ""
    },
    {
      "text": "A 52-year-old man presents with acrocyanosis and hemolysis after exposure to cold temperatures. His direct Coombs' test is positive with cold sub type of antibodies. Which of the following antibodies is most likely responsible for his condition?",
      "options": [
        {
          "label": "A",
          "text": "Anti IgM",
          "correct": false
        },
        {
          "label": "B",
          "text": "Anti IgG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anti IgA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Donath-Landsteiner antibody",
          "correct": true
        }
      ],
      "correct_answer": "D. Donath-Landsteiner antibody",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Donath-Landsteiner antibody</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Anti-IgM would imply an antibody against IgM itself, which is not the cause of cold hemagglutinin disease . Cold agglutinins are typically IgM antibodies that can agglutinate and lyse red blood cells at cold temperatures.</li><li>\u2022 Option A.  Anti-IgM would imply</li><li>\u2022 antibody against IgM</li><li>\u2022 not</li><li>\u2022 cold hemagglutinin disease</li><li>\u2022 Option B.  Anti-IgG suggests an antibody against IgG , which is not typically involved in cold hemagglutinin disease . IgG antibodies can, however, cause warm autoimmune hemolytic anemia .</li><li>\u2022 Option B.  Anti-IgG suggests</li><li>\u2022 antibody against IgG</li><li>\u2022 not</li><li>\u2022 cold hemagglutinin disease</li><li>\u2022 warm autoimmune hemolytic anemia</li><li>\u2022 Option C.  Anti-IgA indicates an antibody against IgA and is not associated with cold hemagglutinin disease.</li><li>\u2022 Option C.  Anti-IgA indicates</li><li>\u2022 antibody against IgA</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Donath-Landsteiner antibody is the cause of paroxysmal cold hemoglobinuria , a rare type of cold hemagglutinin disease , which can present with symptoms like acrocyanosis and hemolysis after cold exposure .</li><li>\u27a4 Donath-Landsteiner antibody</li><li>\u27a4 paroxysmal cold hemoglobinuria</li><li>\u27a4 cold hemagglutinin disease</li><li>\u27a4 acrocyanosis and hemolysis after cold exposure</li><li>\u27a4 Ref : Robbins 10 th / 648</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "410b2e92",
      "audio": ""
    },
    {
      "text": "A patient presents with acrocyanosis and hemolytic anemia after exposure to cold weather. Laboratory tests reveal agglutination of red blood cells at temperatures between 4 to 6\u00b0C. Which type of immunoglobulin is most likely responsible for this agglutination?",
      "options": [
        {
          "label": "A",
          "text": "IgG",
          "correct": false
        },
        {
          "label": "B",
          "text": "IgM",
          "correct": true
        },
        {
          "label": "C",
          "text": "IgA",
          "correct": false
        },
        {
          "label": "D",
          "text": "IgD",
          "correct": false
        }
      ],
      "correct_answer": "B. IgM",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. IgM</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. IgG antibodies are generally involved in warm autoimmune hemolytic anemias and do not typically cause agglutination at low temperatures.</li><li>\u2022 Option A. IgG antibodies</li><li>\u2022 warm autoimmune hemolytic anemias</li><li>\u2022 Option C. IgA antibodies are mainly secretory antibodies and do not usually cause agglutination of red blood cells in cold environments.</li><li>\u2022 Option C. IgA antibodies</li><li>\u2022 secretory antibodies</li><li>\u2022 Option D. IgD antibodies are found in very low concentrations in serum and are not associated with cold agglutination of red blood cells.</li><li>\u2022 Option D. IgD antibodies</li><li>\u2022 very low concentrations in serum</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 IgM antibodies , known as cold agglutinins , can cause agglutination of red blood cells at low temperatures , as seen in cold agglutinin disease .</li><li>\u27a4 IgM antibodies</li><li>\u27a4 cold agglutinins</li><li>\u27a4 agglutination of red blood cells</li><li>\u27a4 low temperatures</li><li>\u27a4 cold agglutinin disease</li><li>\u27a4 Ref : Robbins 10 th / 648</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 648</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45491b77",
      "audio": ""
    },
    {
      "text": "A child presents with acute renal failure, thrombocytopenia, and a microangiopathic hemolytic anemia after a diarrheal illness. A peripheral blood smear shows fragmented red cells, including helmet cells. Which condition is most consistent with these findings?",
      "options": [
        {
          "label": "A",
          "text": "Hemolytic uremic syndrome",
          "correct": true
        },
        {
          "label": "B",
          "text": "Polysplenia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spherocytosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acanthocytosis",
          "correct": false
        }
      ],
      "correct_answer": "A. Hemolytic uremic syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Hemolytic uremic syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Polysplenia is a condition where multiple small spleens are present and is typically associated with congenital abnormalities ; it does not characteristically present with schistocytes or helmet cells.</li><li>\u2022 Option B. Polysplenia</li><li>\u2022 multiple small spleens</li><li>\u2022 congenital abnormalities</li><li>\u2022 Option C. Spherocytosis is a disorder causing spherically shaped red blood cells due to a defect in the RBC membrane, not typically associated with schistocytes or helmet cells.</li><li>\u2022 Option C. Spherocytosis</li><li>\u2022 spherically shaped red blood cells</li><li>\u2022 RBC membrane,</li><li>\u2022 Option D. Acanthocytosis refers to spur cells with spiculated membranes , which are seen in liver disease and abetalipoproteinemia, among others, and does not present with helmet cells.</li><li>\u2022 Option D. Acanthocytosis</li><li>\u2022 spur cells with spiculated membranes</li><li>\u2022 liver disease and abetalipoproteinemia,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Helmet cells on a blood smear are characteristic of microangiopathic hemolytic anemias , such as those seen in hemolytic uremic syndrome (HUS), which can present with renal failure and thrombocytopenia following gastroenteritis .</li><li>\u27a4 Helmet cells</li><li>\u27a4 microangiopathic hemolytic anemias</li><li>\u27a4 hemolytic uremic syndrome (HUS),</li><li>\u27a4 renal failure and thrombocytopenia</li><li>\u27a4 gastroenteritis</li><li>\u27a4 Ref : Robbins 10 th / 662</li><li>\u27a4 Ref : Robbins 10 th / 662</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "61c5b80a",
      "audio": ""
    },
    {
      "text": "A patient presents with fatigue, pallor, and dark urine. Laboratory tests reveal anemia with increased bilirubin levels. Which of the following laboratory findings is inconsistent with a diagnosis of hemolytic anemia?",
      "options": [
        {
          "label": "A",
          "text": "Yellowing of eyes and sclera",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increased LDH",
          "correct": false
        },
        {
          "label": "C",
          "text": "Decrease in haptoglobin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Low reticulocyte count",
          "correct": true
        }
      ],
      "correct_answer": "D. Low reticulocyte count",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Low reticulocyte count</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Yellowing of eyes and sclera is due to hyperbilirubinemia , which is commonly seen in hemolytic anemia as a result of increased breakdown of red blood cells .</li><li>\u2022 Option A. Yellowing of eyes</li><li>\u2022 and sclera</li><li>\u2022 hyperbilirubinemia</li><li>\u2022 hemolytic anemia</li><li>\u2022 increased breakdown of red blood cells</li><li>\u2022 Option B. Increased lactate dehydrogenase (LDH) is often observed in hemolytic anemia because this intracellular enzyme is released into the blood when red cells are destroyed .</li><li>\u2022 Option B. Increased lactate</li><li>\u2022 dehydrogenase</li><li>\u2022 hemolytic anemia</li><li>\u2022 intracellular enzyme</li><li>\u2022 red cells are destroyed</li><li>\u2022 Option C. A decrease in haptoglobin is expected in hemolytic anemia. Haptoglobin binds free hemoglobin released from lysed red blood cells , and its levels drop as it is consumed in this process.</li><li>\u2022 Option C. A decrease in haptoglobin</li><li>\u2022 Haptoglobin binds free hemoglobin</li><li>\u2022 lysed red blood cells</li><li>\u2022 levels drop</li><li>\u2022 consumed</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hemolytic anemia is typically characterized by an increased reticulocyte count as the bone marrow compensates for the loss of red blood cells . A low reticulocyte count suggests an inadequate bone marrow response .</li><li>\u27a4 Hemolytic anemia</li><li>\u27a4 increased reticulocyte count</li><li>\u27a4 bone marrow compensates</li><li>\u27a4 red blood cells</li><li>\u27a4 low reticulocyte count</li><li>\u27a4 inadequate bone marrow response</li><li>\u27a4 Ref: Robbins 10 th / 634</li><li>\u27a4 Ref:</li><li>\u27a4 Robbins 10 th / 634</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "007ea9eb",
      "audio": ""
    },
    {
      "text": "A 6-years-old child belonging to Punjabi family with past history of blood transfusions presented with hemoglobin 3.5 g/dl, MCV \u2013 30 fl, MCHC \u2013 20. Peripheral smear findings of microcytic hypochromic anemia with target cell and reduced osmotic fragility. What is the he probable diagnosis of patient?",
      "options": [
        {
          "label": "A",
          "text": "Alpha thalassemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta thalassemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "G6PD deficiency",
          "correct": false
        }
      ],
      "correct_answer": "B. Beta thalassemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Beta thalassemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alpha thalassemia typically presents with microcytic anemia and can be severe depending on the number of gene deletions but is less common in the Punjabi population.</li><li>\u2022 Option A. Alpha thalassemia</li><li>\u2022 microcytic anemia</li><li>\u2022 severe</li><li>\u2022 number of gene deletions</li><li>\u2022 Option C. Sickle cell anemia usually presents with normocytic anemia and not typically microcytic anemia. It can have target cells but is most commonly associated with the African population.</li><li>\u2022 Option C. Sickle cell anemia</li><li>\u2022 normocytic anemia</li><li>\u2022 African population.</li><li>\u2022 Option D. G6PD deficiency can lead to hemolytic anemia, often episodic and related to oxidative stress, but it typically does not cause a microcytic hypochromic anemia or a reduced MCV and MCHC.</li><li>\u2022 Option D. G6PD deficiency</li><li>\u2022 hemolytic anemia,</li><li>\u2022 oxidative stress,</li><li>\u2022 does not cause a microcytic hypochromic anemia or a reduced</li><li>\u2022 MCV and MCHC.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The  presentation of s evere microcytic hypochromic anemia with target cells , a history of multiple blood transfusions, and reduced osmotic fragility in a child from an ethnicity with a high prevalence of thalassemia strongly suggests beta thalassemia major as the most likely diagnosis.</li><li>\u27a4 evere microcytic hypochromic anemia with target cells</li><li>\u27a4 multiple blood transfusions,</li><li>\u27a4 reduced</li><li>\u27a4 osmotic fragility</li><li>\u27a4 ethnicity with a high prevalence of thalassemia</li><li>\u27a4 beta thalassemia major</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8008edf7",
      "audio": ""
    },
    {
      "text": "NESTROF test is a screening test for which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "\u03b2- thalassemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hereditary spherocytosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Autoimmune haemolytic anaemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Megaloblastic anaemia",
          "correct": false
        }
      ],
      "correct_answer": "A. \u03b2- thalassemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.\u00a0 \u03b2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 \u03b2-thalassemia - NESTROFT is used to screen for beta-thalassemia because red blood cells in this condition exhibit increased fragility in hypotonic solutions due to their membrane characteristics.</li><li>\u2022 \u03b2-thalassemia</li><li>\u2022 NESTROFT is</li><li>\u2022 screen for beta-thalassemia</li><li>\u2022 increased fragility</li><li>\u2022 in hypotonic solutions</li><li>\u2022 membrane characteristics.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NESTROFT is a screening test for beta-thalassemia, which is based on the increased osmotic fragility of red blood cells in this condition.</li><li>\u27a4 NESTROFT</li><li>\u27a4 beta-thalassemia,</li><li>\u27a4 increased osmotic fragility</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9f8385bd",
      "audio": ""
    },
    {
      "text": "Which of the following is the cause of alpha thalassemia?",
      "options": [
        {
          "label": "A",
          "text": "Deletion of alpha genes",
          "correct": true
        },
        {
          "label": "B",
          "text": "Deletion of beta genes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Excess of alpha genes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Single amino acid substitution in alpha chain",
          "correct": false
        }
      ],
      "correct_answer": "A. Deletion of alpha genes",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Deletion of alpha genes</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A:</li><li>\u2022 Option A:</li><li>\u2022 Deletion of alpha genes is the primary cause of alpha thalassemia. The number of deleted genes can affect the severity of the disease ; the loss of two genes causes mild disease, while the loss of all four genes leads to hydrops fetalis .</li><li>\u2022 Deletion of alpha genes</li><li>\u2022 alpha thalassemia.</li><li>\u2022 severity of the disease</li><li>\u2022 loss of two genes</li><li>\u2022 loss of all four genes leads to hydrops fetalis</li><li>\u2022 Option B. Deletion of beta genes leads to beta thalassemia. This condition results from mutations in the beta-globin gene on chromosome 11 , not the alpha-globin gene on chromosome 16.</li><li>\u2022 Option B. Deletion of beta</li><li>\u2022 beta thalassemia.</li><li>\u2022 mutations in the beta-globin gene</li><li>\u2022 chromosome 11</li><li>\u2022 Option C. Excess of alpha genes does not cause alpha thalassemia. Typically, an imbalance between alpha and beta chains due to a relative lack of alpha genes is what causes thalassemias.</li><li>\u2022 Option C. Excess of alpha</li><li>\u2022 does not cause alpha thalassemia.</li><li>\u2022 imbalance between alpha and beta chains</li><li>\u2022 alpha genes</li><li>\u2022 thalassemias.</li><li>\u2022 Option D. Single amino acid substitution in the alpha chain is commonly associated with hemoglobin variants like Hemoglobin C or S, but not with thalassemia , which is a quantitative problem with globin chain production.</li><li>\u2022 Option D. Single amino</li><li>\u2022 alpha chain</li><li>\u2022 Hemoglobin C or S,</li><li>\u2022 not with thalassemia</li><li>\u2022 quantitative problem with globin chain production.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alpha thalassemia is most commonly caused by the deletion of alpha genes on chromosome 16 , which leads to a quantitative reduction in the production of alpha-globin chains.</li><li>\u27a4 Alpha thalassemia</li><li>\u27a4 deletion of alpha genes on chromosome 16</li><li>\u27a4 quantitative reduction</li><li>\u27a4 alpha-globin chains.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a2d72b2",
      "audio": ""
    },
    {
      "text": "HbH is formed due to which of the following?",
      "options": [
        {
          "label": "A",
          "text": "Deletion of 4 alpha chains",
          "correct": false
        },
        {
          "label": "B",
          "text": "Deletion of 3 alpha chains",
          "correct": true
        },
        {
          "label": "C",
          "text": "Deletion of 2 alpha chains",
          "correct": false
        },
        {
          "label": "D",
          "text": "Deletion of 1 alpha chain",
          "correct": false
        }
      ],
      "correct_answer": "B. Deletion of 3 alpha chains",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Deletion of 3 alpha chains</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Deletion of all 4 alpha chains typically results in hydrops fetalis and is usually incompatible with life ; hence it does not lead to the formation of HbH.</li><li>\u2022 Option A. Deletion</li><li>\u2022 of all 4 alpha chains</li><li>\u2022 hydrops fetalis</li><li>\u2022 incompatible with life</li><li>\u2022 Option D. Deletion of 1 alpha chain usually causes no significant clinical symptoms and is known as silent carrier state ; it does not lead to HbH formation.</li><li>\u2022 Option D. Deletion</li><li>\u2022 of 1</li><li>\u2022 alpha chain</li><li>\u2022 silent carrier state</li><li>\u2022 Option C: Deletion of 2 alpha chains often causes a milder form of alpha thalassemia, known as alpha thalassemia trait or alpha thalassemia minor , not typically associated with the formation of HbH.</li><li>\u2022 Option C: Deletion of 2</li><li>\u2022 alpha chains</li><li>\u2022 alpha thalassemia,</li><li>\u2022 alpha thalassemia trait or alpha thalassemia minor</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HbH disease is caused by the deletion of three alpha-globin genes , which leads to an excess of beta-globin chains that form the abnormal hemoglobin H (beta4).</li><li>\u27a4 HbH disease</li><li>\u27a4 deletion of three alpha-globin genes</li><li>\u27a4 excess of beta-globin chains</li><li>\u27a4 abnormal hemoglobin H (beta4).</li><li>\u27a4 Ref : Robbins 10 th / 645</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 645</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "65fb0fb8",
      "audio": ""
    },
    {
      "text": "What is affected in sickled hemoglobin; HbS?",
      "options": [
        {
          "label": "A",
          "text": "Stability",
          "correct": false
        },
        {
          "label": "B",
          "text": "Function",
          "correct": false
        },
        {
          "label": "C",
          "text": "Affinity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Solubility",
          "correct": true
        }
      ],
      "correct_answer": "D. Solubility",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Solubility</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Stability refers to the hemoglobin molecule's resistance to denaturation and degradation . While HbS can be less stable under deoxygenating conditions, this is not the primary issue.</li><li>\u2022 Option A. Stability</li><li>\u2022 hemoglobin molecule's resistance to denaturation and degradation</li><li>\u2022 Option B. Function pertains to the ability of hemoglobin to carry oxygen . HbS can still carry oxygen , but the sickling process can hinder its release to tissues.</li><li>\u2022 Option B. Function pertains</li><li>\u2022 ability</li><li>\u2022 carry oxygen</li><li>\u2022 carry oxygen</li><li>\u2022 Option C. Affinity refers to the hemoglobin's ability to bind oxygen . HbS has a slightly different oxygen affinity compared to normal hemoglobin, but again, this is not the main problem.</li><li>\u2022 Option C. Affinity refers</li><li>\u2022 hemoglobin's ability</li><li>\u2022 bind oxygen</li><li>\u2022 HbS</li><li>\u2022 slightly different oxygen</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sickle cell hemoglobin (HbS) is primarily characterized by reduced solubility under deoxygenated conditions, leading to polymerization and sickling of red blood cells. This results in vaso-occlusive crises and chronic hemolytic anemia.</li><li>\u27a4 Sickle cell hemoglobin (HbS)</li><li>\u27a4 reduced solubility</li><li>\u27a4 deoxygenated</li><li>\u27a4 polymerization and sickling</li><li>\u27a4 vaso-occlusive crises and chronic hemolytic anemia.</li><li>\u27a4 Ref : Robbins 10 th / 638</li><li>\u27a4 Ref : Robbins 10 th / 638</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "63a26d90",
      "audio": ""
    },
    {
      "text": "A 56-year\u2011old female presents in the month of December with chronic fatigue and cyanosis of nose with blue lips. A peripheral blood smear showed the following image. What is the most likely cause of the findings seen?",
      "options": [
        {
          "label": "A",
          "text": "Clumps of RBCs due to IgM mediated cold autoim\u00admune haemolytic anemia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Clumps of RBCs due to IgG mediated warm auto\u00adimmune haemolytic anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "RBC lysis due to hemoglobinopathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clumps of RBCs due to IgG mediated cold autoim\u00admune haemolytic anemia \u200b\u200b\u200b\u200b\u200b\u200b",
          "correct": false
        }
      ],
      "correct_answer": "A. Clumps of RBCs due to IgM mediated cold autoim\u00admune haemolytic anemia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/26/picture1_67TV6O2.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Clumps of RBCs due to IgM mediated cold autoimmune haemolytic anemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Warm autoimmune hemolytic anemia (WAIHA) involves IgG antibodies that react with red blood cells at body temperature, leading to their destruction by the spleen . This would not typically be associated with cold exposure and is not consistent with the symptom of cyanosis, which is related to cold.</li><li>\u2022 Option B. Warm autoimmune</li><li>\u2022 IgG antibodies</li><li>\u2022 at body temperature,</li><li>\u2022 spleen</li><li>\u2022 Option C. Hemoglobinopathies, such as sickle cell disease , can cause hemolytic anemia , but the red blood cells do not clump in response to cold. Instead, hemoglobinopathies typically involve structural abnormalities of the hemoglobin molecule itself.</li><li>\u2022 Option C. Hemoglobinopathies,</li><li>\u2022 sickle cell disease</li><li>\u2022 hemolytic anemia</li><li>\u2022 red blood cells do not clump in</li><li>\u2022 response to cold.</li><li>\u2022 structural abnormalities of the hemoglobin molecule itself.</li><li>\u2022 Option D. Cold agglutinin disease can sometime s involve IgG antibodies , but it is more commonly associated with IgM antibodies. IgG-mediated hemolysis at cold temperatures is much less common and would not explain the typical clumping seen in CAHA.</li><li>\u2022 Option D. Cold agglutinin</li><li>\u2022 sometime</li><li>\u2022 IgG antibodies</li><li>\u2022 more commonly associated with IgM antibodies.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 It is important to recognize the clinical and laboratory findings consistent with cold autoimmune hemolytic anemia (CAHA), where IgM antibodies bind to red blood cells at low temperatures , causing them to agglutinate . This can lead to hemolytic anemia , resulting in symptoms such as chronic fatigue and cyanosis upon cold exposure.</li><li>\u27a4 cold autoimmune hemolytic anemia (CAHA),</li><li>\u27a4 IgM antibodies bind to red blood cells at low temperatures</li><li>\u27a4 to agglutinate</li><li>\u27a4 hemolytic anemia</li><li>\u27a4 chronic fatigue and cyanosis</li><li>\u27a4 Ref : Robbins 10 th / 643-4</li><li>\u27a4 Ref : Robbins 10 th / 643-4</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e37c945",
      "audio": ""
    },
    {
      "text": "All of the following if present provide protection against malaria except:",
      "options": [
        {
          "label": "A",
          "text": "Duffy blood group",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sickle cell anemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thalassemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "G6PD deficiency",
          "correct": false
        }
      ],
      "correct_answer": "A. Duffy blood group",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Duffy blood group</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sickle cell disease: P falciparum cannot multiply properly in the presence of HbS \u03b1 and \u03b2 thalassemia:</li><li>\u2022 Option B. Sickle cell disease:</li><li>\u2022 HbS \u03b1 and \u03b2 thalassemia:</li><li>\u2022 Option D. G6 PD deficiency: G6PD is required for respiration of plas\u00acmodium</li><li>\u2022 Option D. G6 PD deficiency:</li><li>\u2022 respiration of plas\u00acmodium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency are all known to confer some protection against malaria due to various mechanisms that interfere with the parasite's ability to infect or survive within red blood cells . However, the Duffy blood group's absence , while protective against Plasmodium vivax , does not provide protection against P. falciparum, the most common and virulent cause of malaria.</li><li>\u27a4 absence of the Duffy blood group, the trait for sickle cell disease, thalassemia traits, and G6PD deficiency</li><li>\u27a4 against malaria</li><li>\u27a4 parasite's ability to infect or survive within red blood cells</li><li>\u27a4 Duffy blood group's absence</li><li>\u27a4 against Plasmodium vivax</li><li>\u27a4 does not provide protection against P. falciparum, the most common and virulent cause of malaria.</li><li>\u27a4 Ref : Robbins 10 th / 403</li><li>\u27a4 Ref : Robbins 10 th / 403</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "623437c4",
      "audio": ""
    },
    {
      "text": "Myelofibrosis leading to a dry tap on bone marrow aspiration is seen with which of the following conditions?",
      "options": [
        {
          "label": "A",
          "text": "Burkitt\u2019s lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute erythroblastic leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acute megakaryocytic leukemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acute undifferentiated leukemia",
          "correct": false
        }
      ],
      "correct_answer": "C. Acute megakaryocytic leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Acute megakaryocytic leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Burkitt\u2019s lymphoma is a type of non-Hodgkin lymphoma that primarily involves B cells. It typically presents with rapidly growing tumors , often in the jaw or abdomen . Bone marrow involvement in Burkitt's lymphoma is uncommon. While bone marrow examination may reveal lymphoma cells , it is not typically associated with myelofibrosis, and a dry tap is not a characteristic finding.</li><li>\u2022 Option A:</li><li>\u2022 Burkitt\u2019s lymphoma</li><li>\u2022 non-Hodgkin lymphoma</li><li>\u2022 B cells.</li><li>\u2022 rapidly</li><li>\u2022 growing tumors</li><li>\u2022 jaw or abdomen</li><li>\u2022 bone marrow</li><li>\u2022 lymphoma cells</li><li>\u2022 not</li><li>\u2022 myelofibrosis, and a dry tap</li><li>\u2022 Option B: Acute erythroblastic leukemia (erythroleukemia) is a rare subtype of acute myeloid leukemia (AML) characterized by the proliferation of immature erythroid precursors . This condition can infiltrate the bone marrow , leading to a hypercellular marrow with an excess o f erythroid precursors . Myelofibrosis and dry tap are not typical features of acute erythroblastic leukemia.</li><li>\u2022 Option B:</li><li>\u2022 Acute erythroblastic leukemia (erythroleukemia)</li><li>\u2022 subtype of acute myeloid leukemia (AML)</li><li>\u2022 proliferation of immature erythroid precursors</li><li>\u2022 infiltrate the bone marrow</li><li>\u2022 hypercellular marrow</li><li>\u2022 f erythroid precursors</li><li>\u2022 Option D: Acute undifferentiated leukemia refers to a subtype of acute leukemia in which the blasts (immature cells) in the bone marrow lack specific features that would allow classification into myeloid or lymphoid lineages. While acute leukemias can sometimes be associated with bone marrow fibrosis , the dry tap is not typically a defining feature of this subtype.</li><li>\u2022 Option D: Acute undifferentiated leukemia</li><li>\u2022 subtype of acute leukemia</li><li>\u2022 blasts (immature cells)</li><li>\u2022 lack specific features</li><li>\u2022 myeloid or lymphoid lineages.</li><li>\u2022 acute leukemias</li><li>\u2022 bone marrow fibrosis</li><li>\u2022 dry tap is not</li><li>\u2022 subtype.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute megakaryocytic leukemia , a subtype of acute myeloid leukemia characterized by the proliferation of megakaryocytic precursors , is associated with the development of myelofibrosis within the bone marrow, which can lead to a ' dry tap' during bone marrow aspiration due to increased fibrous tissue.</li><li>\u27a4 Acute megakaryocytic leukemia</li><li>\u27a4 subtype of acute myeloid leukemia</li><li>\u27a4 proliferation of megakaryocytic</li><li>\u27a4 precursors</li><li>\u27a4 development of myelofibrosis</li><li>\u27a4 dry tap'</li><li>\u27a4 bone</li><li>\u27a4 marrow aspiration due to increased fibrous tissue.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "72ac67ac",
      "audio": ""
    },
    {
      "text": "Which of the following is the least likely to be a pre-leukaemic condition?",
      "options": [
        {
          "label": "A",
          "text": "Paroxysmal nocturnal haemoglobinuria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aplastic anaemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Paroxysmal cold haemoglobinuria",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myelodysplastic syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Paroxysmal cold haemoglobinuria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Paroxysmal cold haemoglobinuria</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: \u201cPNH: about 5% to 10% of patients eventually develop acute myeloid leukemia or a my\u00adelodysplastic syndrome , possibly because hematopoietic stem cells have suffered some type of genetic damage \u2019.</li><li>\u2022 Option A: \u201cPNH:</li><li>\u2022 5% to 10%</li><li>\u2022 acute myeloid leukemia or a my\u00adelodysplastic syndrome</li><li>\u2022 hematopoietic stem cells</li><li>\u2022 genetic damage</li><li>\u2022 Option B: Aplastic anemia results from a fundamental stem cell defect supported by the presence of karyotypic aberrations in many cases; the occasional trans\u00adformation of aplasia into myeloid neoplasms , typically myelodysplasia or acute myeloid leukemia; and the asso\u00adciation with abnormally short telomeres .</li><li>\u2022 Option B:</li><li>\u2022 Aplastic anemia</li><li>\u2022 stem cell defect</li><li>\u2022 karyotypic aberrations</li><li>\u2022 aplasia into myeloid neoplasms</li><li>\u2022 myelodysplasia or acute myeloid leukemia;</li><li>\u2022 short telomeres</li><li>\u2022 Option D: The term \u201cmyelodysplastic syndrome\u201d (MDS) refers to a group of clonal stem cell disorders characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation to AML .</li><li>\u2022 Option D:</li><li>\u2022 \u201cmyelodysplastic syndrome\u201d</li><li>\u2022 clonal stem cell disorders</li><li>\u2022 maturation defects</li><li>\u2022 ineffective hematopoiesis</li><li>\u2022 high risk of transformation to AML</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Paroxysmal Cold Hemoglobinuria (PCH) is primarily an autoimmune hemolytic anemia and not commonly associated with transformation to leukemia , which makes it the least likely condition to be pre-leukemic .</li><li>\u2022 Paroxysmal Cold Hemoglobinuria (PCH)</li><li>\u2022 autoimmune hemolytic anemia</li><li>\u2022 not commonly</li><li>\u2022 transformation to leukemia</li><li>\u2022 least likely condition to be pre-leukemic</li><li>\u2022 (Ref: Robbins 10 th / 545)</li><li>\u2022 (Ref: Robbins 10 th / 545)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0377a018",
      "audio": ""
    },
    {
      "text": "Which of the following statements pertaining to leukemia is correct?",
      "options": [
        {
          "label": "A",
          "text": "Blasts of acute myeloid leukemia are typically Su\u00addan black negative",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blasts of acute lymphoblastic leukemia are typically myeloperoxidase positive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Low leucocyte alkaline phosphatase score is charac\u00adteristically seen in blastic phase of chronic myeloid leukemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Tartarate resistant acid phosphatase positivity is typically seen in hairy cell leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Blasts in acute myeloid leukemia (AML) are often Sudan black positive . This histochemical stain is used to detect the presence of myeloid granules in blasts , which are typically abundant in AML cells .</li><li>\u2022 Option A:</li><li>\u2022 Blasts</li><li>\u2022 acute myeloid leukemia (AML)</li><li>\u2022 Sudan black positive</li><li>\u2022 myeloid granules in blasts</li><li>\u2022 abundant in AML cells</li><li>\u2022 Option B: Blasts of acute lymphoblastic leukemia (ALL) are generally myeloperoxidase (MPO) negative . MPO is an enzyme found predominantly in myeloid cells and is used as a marker to distinguish AML (where blasts are typically MPO positive) from ALL .</li><li>\u2022 Option B:</li><li>\u2022 Blasts of acute lymphoblastic leukemia (ALL)</li><li>\u2022 myeloperoxidase (MPO) negative</li><li>\u2022 myeloid cells</li><li>\u2022 distinguish AML (where blasts are typically MPO positive) from ALL</li><li>\u2022 Option C: A low leukocyte alkaline phosphatase (LAP) score is seen in the chronic phase of chronic myeloid leukemia (CML), reflecting the abundance of immature leukocytes. However, the LAP score often increases when CML progresses to the blast crisis phase , due to the presence of a higher proportion of mature leukocytes.</li><li>\u2022 Option C:</li><li>\u2022 low leukocyte alkaline phosphatase (LAP)</li><li>\u2022 chronic myeloid leukemia (CML),</li><li>\u2022 immature leukocytes.</li><li>\u2022 LAP score</li><li>\u2022 increases</li><li>\u2022 CML progresses to the blast crisis phase</li><li>\u2022 higher</li><li>\u2022 mature leukocytes.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tartarate resistant acid phosphatase (TRAP) positivity is typically seen in hairy cell leukemia (HCL), which is useful for its diagnosis and differentiation from other hematologic disorders.</li><li>\u27a4 Tartarate resistant acid phosphatase (TRAP) positivity</li><li>\u27a4 hairy cell leukemia (HCL),</li><li>\u27a4 diagnosis and differentiation</li><li>\u27a4 hematologic disorders.</li><li>\u27a4 (Ref: Robbins 10 th / 604)</li><li>\u27a4 (Ref: Robbins 10 th / 604)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2a422e4",
      "audio": ""
    },
    {
      "text": "Which of the following is having poor prognosis in ALL?",
      "options": [
        {
          "label": "A",
          "text": "TLC 4000-10000",
          "correct": false
        },
        {
          "label": "B",
          "text": "Age < 10 year",
          "correct": false
        },
        {
          "label": "C",
          "text": "Presence of testicular involvement at presentation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Presence of blasts in peripheral smear",
          "correct": false
        }
      ],
      "correct_answer": "C. Presence of testicular involvement at presentation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Presence of testicular involvement at presenta\u00adtion</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (TLC 4000-10000): Total leukocyte count (TLC) at presentation is an important prognostic factor in ALL . Normal or moderately elevated TLCs are generally associated with a better prognosis . A very high TLC , particularly above 100,000, is typically considered a poor prognostic indicator in ALL , particularly in T-cell ALL .</li><li>\u2022 Option A: (TLC 4000-10000):</li><li>\u2022 prognostic factor in ALL</li><li>\u2022 Normal or moderately elevated TLCs</li><li>\u2022 better prognosis</li><li>\u2022 very high TLC</li><li>\u2022 100,000,</li><li>\u2022 poor prognostic indicator in ALL</li><li>\u2022 T-cell ALL</li><li>\u2022 Option B: (Age < 10 year): Age is a significant prognostic factor in ALL. Children under 1 year of age and adults over 35 years of age have a poorer prognosis compared to children aged 1 to 10 years, who tend to respond better to therapy .</li><li>\u2022 Option B: (Age < 10 year):</li><li>\u2022 under 1 year of age</li><li>\u2022 35 years of age</li><li>\u2022 poorer prognosis</li><li>\u2022 1 to 10 years,</li><li>\u2022 better to therapy</li><li>\u2022 Option D: (Presence of blasts in peripheral smear): The presence of blasts in the peripheral blood smear is characteristic of ALL but on its own is not necessarily a poor prognostic indicator . The percentage and the total number of blasts can provide more specific prognostic information , with a higher burden sometimes indicating more aggressive disease.</li><li>\u2022 Option D: (Presence of blasts in peripheral smear):</li><li>\u2022 blasts</li><li>\u2022 not necessarily a poor prognostic indicator</li><li>\u2022 total number of blasts</li><li>\u2022 more specific prognostic information</li><li>\u2022 higher burden</li><li>\u2022 more aggressive disease.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of testicular involvement at presentation in Acute Lymphoblastic Leukemia (ALL) is associated with a poorer prognosis due to the risk of extramedullary relapse and the need for more aggressive treatment .</li><li>\u27a4 presence of testicular</li><li>\u27a4 Acute Lymphoblastic Leukemia (ALL)</li><li>\u27a4 poorer prognosis</li><li>\u27a4 extramedullary relapse</li><li>\u27a4 more aggressive treatment</li><li>\u27a4 Prognostic factors in ALL</li><li>\u27a4 Prognostic factors in ALL</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f747bd8",
      "audio": ""
    },
    {
      "text": "AML with gum infiltration and hepatosplenomegaly is most likely associated with which of the following subtypes of AML?",
      "options": [
        {
          "label": "A",
          "text": "M1",
          "correct": false
        },
        {
          "label": "B",
          "text": "M3",
          "correct": false
        },
        {
          "label": "C",
          "text": "M2",
          "correct": false
        },
        {
          "label": "D",
          "text": "M4",
          "correct": true
        }
      ],
      "correct_answer": "D. M4",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) M4</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: (M1 - Acute Myeloblastic Leukemia without maturation): M1 subtype is characterized by a proliferation of myeloblasts without significant differentiation . While organomegaly can occur , M1 is not typically associated with gum infiltration.</li><li>\u2022 Option A: (M1 - Acute Myeloblastic Leukemia without maturation):</li><li>\u2022 proliferation of myeloblasts without</li><li>\u2022 differentiation</li><li>\u2022 organomegaly can occur</li><li>\u2022 not</li><li>\u2022 gum infiltration.</li><li>\u2022 Option B: (M3 - Acute Promyelocytic Leukemia): M3 subtype is unique due to its association with the t(15;17) translocation and the PML-RARA fusion gene . It can present with disseminated intravascular coagulation (DIC), but gum infiltration is less characteristic of M3 .</li><li>\u2022 Option B: (M3 - Acute Promyelocytic Leukemia):</li><li>\u2022 M3 subtype</li><li>\u2022 t(15;17) translocation</li><li>\u2022 PML-RARA fusion gene</li><li>\u2022 disseminated intravascular coagulation (DIC),</li><li>\u2022 gum infiltration</li><li>\u2022 less</li><li>\u2022 M3</li><li>\u2022 Option C: (M2 - Acute Myeloblastic Leukemia with maturation): M2 subtype shows some degree of myeloid maturation . It can occasionally involve extramedullary sites , but gum infiltration and hepatosplenomegaly are more typical of AML with monocytic differentiation , such as M4 and M5 .</li><li>\u2022 Option C: (M2 - Acute Myeloblastic Leukemia with maturation):</li><li>\u2022 M2</li><li>\u2022 degree of myeloid maturation</li><li>\u2022 extramedullary sites</li><li>\u2022 gum infiltration and hepatosplenomegaly</li><li>\u2022 more typical of AML with monocytic differentiation</li><li>\u2022 M4 and M5</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Acute Myelomonocytic Leukemia (M4) is commonly associated with extramedullary manifestations such as gum infiltration and hepatosplenomegaly due to the infiltrative nature of the monocytic component of the leukemia.</li><li>\u27a4 Acute Myelomonocytic Leukemia (M4)</li><li>\u27a4 gum infiltration and hepatosplenomegaly</li><li>\u27a4 infiltrative nature of the monocytic component</li><li>\u27a4 (Ref: Robbins 10 th / 618)</li><li>\u27a4 (Ref: Robbins 10 th / 618)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "648f56e4",
      "audio": ""
    },
    {
      "text": "A peripheral smear with increased neutrophils, basophils, eosinophils, and platelets is highly suggestive of:",
      "options": [
        {
          "label": "A",
          "text": "Acute myeloid leukemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acute lymphoblastic leukemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chronic myelogenous leukemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Myelodysplastic syndrome",
          "correct": false
        }
      ],
      "correct_answer": "C. Chronic myelogenous leukemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Chronic myelogenous leukemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Acute Myeloid Leukemia (AML): is characterized by the rapid growth of abnormal myeloid cells in the bone marrow. While AML may show increased myeloid cells in the peripheral smear, it typically presents with blasts and a decrease in mature cells , unlike the broad spectrum of increased cells seen in the question.</li><li>\u2022 Option A:</li><li>\u2022 Acute Myeloid Leukemia (AML):</li><li>\u2022 rapid growth</li><li>\u2022 abnormal myeloid cells</li><li>\u2022 increased myeloid cells</li><li>\u2022 blasts and a decrease in mature cells</li><li>\u2022 Option B: Acute Lymphoblastic Leukemia (ALL): primarily affects lymphoid cells . It is characterized by the presence of lymphoblasts in the peripheral blood. The question describes an increase in myeloid cell lineages (neutrophils, basophils, eosinophils, and platelets), making ALL less likely.</li><li>\u2022 Option B:</li><li>\u2022 Acute Lymphoblastic Leukemia (ALL):</li><li>\u2022 primarily affects lymphoid cells</li><li>\u2022 lymphoblasts</li><li>\u2022 Option D: Myelodysplastic Syndrome (MDS): is a group of disorders characterized by ineffective hematopoiesis . While MDS can present with cytopenias and dysplastic changes in blood cells, the specific pattern described in the question (increased neutrophils, basophils, eosinophils, and platelets) is more indicative of CML.</li><li>\u2022 Option D:</li><li>\u2022 Myelodysplastic Syndrome (MDS):</li><li>\u2022 group of disorders</li><li>\u2022 ineffective hematopoiesis</li><li>\u2022 cytopenias and dysplastic</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Chronic myeloid leukemia is a stem cell disease that is characterized by leukocytosis with granulocytic immaturities, basophilia, splenomegaly and distinct chromosomal abnormality Philadelphia chromosome .</li><li>\u2022 Chronic myeloid leukemia</li><li>\u2022 stem cell disease</li><li>\u2022 leukocytosis with granulocytic immaturities, basophilia, splenomegaly</li><li>\u2022 Philadelphia chromosome</li><li>\u2022 (Ref: Robbins 10 th / 622)</li><li>\u2022 (Ref: Robbins 10 th / 622)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45efbecf",
      "audio": ""
    }
  ]
}